Positive	O
and	O
negative	O
regulation	O
of	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
promoter	O
activity	O
by	O
AML1-related	B-protein
transcription	I-protein
factor	I-protein
,	O
PEBP2	B-protein
.	O

The	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
(	I-DNA
GM-CSF	I-DNA
)	I-DNA
gene	I-DNA
promoter	I-DNA
contains	O
a	O
consensus	O
sequence	O
for	O
the	O
polyomavirus	B-protein
enhancer	I-protein
binding-protein	I-protein
2	I-protein
(	I-protein
PEBP2	I-protein
)	I-protein
transcription	I-protein
factor	I-protein
,	O
which	O
consists	O
of	O
alpha	B-protein
and	I-protein
beta	I-protein
subunits	I-protein
.	O

There	O
are	O
at	O
least	O
two	O
genes	O
,	O
alpha	B-DNA
A	I-DNA
and	O
alpha	B-DNA
B	I-DNA
,	O
encoding	O
the	O
alpha	B-protein
subunit	I-protein
.	O

alpha	B-DNA
B	I-DNA
is	O
the	O
mouse	B-DNA
homologue	I-DNA
of	O
human	B-DNA
AML1	I-DNA
gene	I-DNA
detected	O
at	O
the	O
breakpoints	O
of	O
t	O
(	O
8	O
;	O
21	O
)	O
and	O
t	O
(	O
3	O
;	O
21	O
)	O
myeloid	O
leukemias	O
.	O

We	O
examined	O
alpha	B-protein
A1	I-protein
(	O
an	O
alpha	B-protein
A-gene	I-protein
product	I-protein
)	O
and	O
alpha	B-protein
B1	I-protein
and	O
alpha	B-protein
B2	I-protein
(	O
two	O
alpha	B-protein
B-encoded	I-protein
isomers	I-protein
)	O
for	O
their	O
effects	O
on	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
.	O

PEBP2	B-protein
alpha	I-protein
A1	I-protein
,	O
alpha	B-protein
B1	I-protein
,	O
and	O
alpha	B-protein
B2	I-protein
proteins	I-protein
bound	O
the	O
PEBP2	B-DNA
site	I-DNA
within	O
the	O
mouse	B-DNA
GM-CSF	I-DNA
promoter	I-DNA
.	O

PEBP2	B-protein
alpha	I-protein
A1	I-protein
and	O
alpha	B-protein
B1	I-protein
enhanced	O
the	O
expression	O
of	O
the	O
GM-CSF	B-DNA
promoter-driven	I-DNA
reporter	I-DNA
plasmid	I-DNA
in	O
unstimulated	B-cell_line
and	I-cell_line
12-O-tetradecanoylphorbol	I-cell_line
13-acetate/phytohemagglutinin-stimulated	I-cell_line
human	I-cell_line
Jurkat	I-cell_line
T	I-cell_line
cells	I-cell_line
.	O

In	O
contrast	O
,	O
the	O
promoter	O
activity	O
was	O
suppressed	O
by	O
alpha	B-protein
B2	I-protein
.	O

Coexpression	O
of	O
alpha	B-protein
B1	I-protein
and	O
alpha	B-protein
B2	I-protein
showed	O
that	O
the	O
promoter	O
activity	O
could	O
be	O
determined	O
by	O
the	O
alpha	B-protein
B1	I-protein
/alpha	B-protein
B2	I-protein
ratio	O
.	O

Jurkat	O
cell	O
extract	O
contained	O
PEBP2	B-protein
site-binding	I-protein
protein	I-protein
(	O
s	O
)	O
that	O
cross-reacted	O
with	O
antimouse	B-protein
alpha	I-protein
A1	I-protein
antibodies	I-protein
.	O

Northern	O
blot	O
analysis	O
indicated	O
the	O
expression	O
of	O
human	O
PEBP2	B-protein
alpha	I-protein
A	I-protein
,	O
alpha	B-DNA
B	I-DNA
(	O
AML1	B-DNA
)	O
,	O
and	O
beta	B-DNA
genes	I-DNA
in	O
Jurkat	B-cell_line
cells	I-cell_line
.	O

Although	O
further	O
studies	O
are	O
required	O
to	O
determine	O
the	O
precise	O
role	O
of	O
PEBP2	B-protein
in	O
the	O
GM-CSF	B-protein
promoter	O
activity	O
,	O
the	O
present	O
findings	O
suggested	O
the	O
importance	O
of	O
the	O
relative	O
ratio	O
of	O
different	O
PEBP2	B-protein
isoforms	I-protein
in	O
regulating	O
the	O
levels	O
of	O
the	O
promoter	O
activity	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Positive	NULL
and	NULL
Negative	NULL
Regulation	NULL
of	NULL
Granulocyte-	NULL
Macrophage	NULL
Colony-Stimulating	NULL
Factor	NULL
Promoter	NULL
Activity	NULL
by	NULL
AML1-Related	NULL
Transcription	NULL
Factor	NULL
,	NULL
PEBP2	NULL
By	NULL
Atsushi	NULL
Takahashi	NULL
,	NULL
Masanobu	NULL
Satake	NULL
,	NULL
Yuko	NULL
Yamaguchi-lwai	NULL
,	NULL
Suk-Chul	NULL
Bae	NULL
,	NULL
Jie	NULL
Lu	NULL
,	NULL
Mitsuo	NULL
Maruyama	NULL
,	NULL
Yu	NULL
Wen	NULL
Zhang	NULL
,	NULL
Hiroya	NULL
Oka	NULL
,	NULL
Naoko	NULL
Arai	NULL
,	NULL
Ken-ichi	NULL
Arai	NULL
,	NULL
and	NULL
Yoshiaki	NULL
Ito	NULL
The	NULL
-	NULL
granulocyte-macrophage	NULL
-	NULL
colony-stimulating	NULL
-	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
promoter	NULL
contains	NULL
a	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
binding-protein	NULL
2	NULL
(	NULL
PEBP2	NULL
)	NULL
transcription	NULL
factor	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
a	NULL
and	NULL
B	NULL
subunits	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
two	NULL
genes	NULL
,	NULL
aA	NULL
and	NULL
«	NULL
B	NULL
,	NULL
encoding	NULL
the	NULL
a	NULL
subunit	NULL
.	NULL

aB	NULL
is	NULL
the	NULL
mouse	NULL
homologue	NULL
of	NULL
human	NULL
AML	NULL
1	NULL
gene	NULL
detected	NULL
at	NULL
the	NULL
breakpoints	NULL
of	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
and	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
myeloid	NULL
leukemias	NULL
.	NULL

We	NULL
examined	NULL
«	NULL
A1	NULL
(	NULL
an	NULL
aA-gene	NULL
product	NULL
)	NULL
and	NULL
aB1	NULL
and	NULL
«	NULL
B2	NULL
{	NULL
two	NULL
aB-encoded	NULL
isomers	NULL
)	NULL
for	NULL
their	NULL
effects	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

PEBP2	NULL
«	NULL
eA1	NULL
,	NULL
«	NULL
B1	NULL
,	NULL
and	NULL
«	NULL
B2	NULL
proteins	NULL
bound	NULL
the	NULL
PEBP2	NULL
site	NULL
within	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

PEBP2aeA1	NULL
and	NULL
aB1	NULL
enhanced	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter-driven	NULL
reporter	NULL
plasmid	NULL
in	NULL
unstimulated	NULL
and	NULL
12-O-tetradecanoylphorbol	NULL
13	NULL
-	NULL
acetate	NULL
/	NULL
phytohemagglutinin	NULL
-	NULL
stimulated	NULL
RANULOCYTE-MACROPHAGE	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
!	NULL

is	NULL
a	NULL
multifunctional	NULL
cytokine	NULL
with	NULL
diverse	NULL
biologic	NULL
activities	NULL
such	NULL
as	NULL
the	NULL
control	NULL
of	NULL
hematopoie-sis	NULL
``	NULL
and	NULL
the	NULL
enhancement	NULL
of	NULL
functions	NULL
and	NULL
survival	NULL
of	NULL
mature	NULL
leukocytes	NULL
involved	NULL
in	NULL
the	NULL
host	NULL
defense	NULL
against	NULL
microor-ganisms	NULL
.	NULL

*	NULL
Its	NULL
overproduction	NULL
or	NULL
inappropriate	NULL
expression	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
establishment	NULL
of	NULL
inflammatory	NULL
dis-eases	NULL
``	NULL
and	NULL
in	NULL
the	NULL
autocrine	NULL
growth	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
AML	NULL
)	NULL
cells	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
elucidation	NULL
of	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
its	NULL
production	NULL
may	NULL
provide	NULL
insights	NULL
into	NULL
the	NULL
patho-physiology	NULL
of	NULL
immune-mediated	NULL
injury	NULL
and	NULL
leukemogenesis	NULL
.	NULL
``	NULL

The	NULL
regulation	NULL
of	NULL
GM-CSF	NULL
expression	NULL
involves	NULL
both	NULL
tran-and	NULL
posttranscriptional	NULL
``	NULL
``	NULL
``	NULL
°	NULL
control	NULL
mecha-nisms	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
respond	NULL
to	NULL
agents	NULL
mimicking	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
signaling	NULL
,	NULL
such	NULL
as	NULL
12-O-tetradecanoylphorbol	NULL
13-ace-tate	NULL
(	NULL
TPA	NULL
)	NULL
plus	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
or	NULL
TPA	NULL
plus	NULL
A23187	NULL
.	NULL
``	NULL

''	NULL
The	NULL
promoter	NULL
contains	NULL
several	NULL
elements	NULL
highly	NULL
conserved	NULL
between	NULL
murine	NULL
and	NULL
human	NULL
genes	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
CLE1	NULL
(	NULL
CK-1	NULL
)	NULL
,	NULL
CLE2	NULL
(	NULL
CK-2	NULL
)	NULL
,	NULL
``	NULL
``	NULL
°	NULL
GM-	NULL
«	NULL
B	NULL
,	NULL
``	NULL
``	NULL
``	NULL
``	NULL
GC	NULL
box	NULL
,	NULL
``	NULL
``	NULL
CATT	NULL
(	NULL
A/T	NULL
)	NULL
repeat	NULL
,	NULL
``	NULL
and	NULL
CLEO	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Deletion	NULL
analysis	NULL
has	NULL
indicated	NULL
that	NULL
the	NULL
region	NULL
from	NULL
nucleotide	NULL
-95	NULL
to	NULL
+27	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
is	NULL
capable	NULL
of	NULL
mediating	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
TPA/A23187	NULL
in	NULL
human	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
.	NULL
``	NULL

GM-	NULL
«	NULL
B/GC-box	NULL
(	NULL
-95	NULL
to	NULL
-73	NULL
)	NULL
and	NULL
CLEO	NULL
(	NULL
-54	NULL
to	NULL
-40	NULL
)	NULL
within	NULL
the	NULL
region	NULL
are	NULL
required	NULL
for	NULL
the	NULL
inducibility	NULL
.	NULL

'~	NULL
'	NULL
>	NULL
44'523	NULL
In	NULL
addition	NULL
to	NULL
the	NULL
highly	NULL
conserved	NULL
elements	NULL
mentioned	NULL
above	NULL
,	NULL
we	NULL
recognized	NULL
that	NULL
the	NULL
sequence	NULL
located	NULL
at	NULL
-64	NULL
to	NULL
-58	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
is	NULL
also	NULL
totally	NULL
conserved	NULL
between	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
human	NULL
genes	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
agrees	NULL
with	NULL
the	NULL
consensus	NULL
sequence	NULL
,	NULL
Pu/TAC-CPuCA	NULL
,	NULL
*	NULL
``	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
binding-protein	NULL
2	NULL
(	NULL
PEBP2	NULL
)	NULL
.	NULL

``	NULL
*	NULL
``	NULL
°	NULL
PEBP2	NULL
,	NULL
also	NULL
called	NULL
CBF	NULL
,	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
recognizing	NULL
the	NULL
PEA	NULL
site	NULL
``	NULL
``	NULL
within	NULL
the	NULL
polyomavirus	NULL
(	NULL
Py	NULL
)	NULL
enhancer	NULL
A	NULL
core	NULL
and	NULL
playing	NULL
an	NULL
important	NULL
role	NULL
in	NULL
transcription	NULL
and	NULL
replication	NULL
of	NULL
Py	NULL
DNA	NULL
.	NULL

**	NULL
``	NULL
°	NULL
The	NULL
A	NULL
core	NULL
contains	NULL
the	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
API	NULL
and	NULL
Ets	NULL
family	NULL
proteins	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
PEBP2	NULL
site	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
sequence	NULL
arrangement	NULL
around	NULL
the	NULL
PEBP2	NULL
consensus	NULL
Blood	NULL
,	NULL
Vol	NULL
86	NULL
,	NULL
No	NULL
2	NULL
(	NULL
July	NULL
15	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
607-616	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
suppressed	NULL
by	NULL
«	NULL
B2	NULL
.	NULL

Coexpression	NULL
of	NULL
«	NULL
B1	NULL
and	NULL
«	NULL
B2	NULL
showed	NULL
that	NULL
the	NULL
promoter	NULL
activity	NULL
could	NULL
be	NULL
determined	NULL
by	NULL
the	NULL
aB1/	NULL
aB2	NULL
ratio	NULL
.	NULL

Jurkat	NULL
cell	NULL
extract	NULL
contained	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
cross-reacted	NULL
with	NULL
antimouse	NULL
«	NULL
A1	NULL
antibod-ies	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
indicated	NULL
the	NULL
expression	NULL
of	NULL
human	NULL
PEBP2aeA	NULL
,	NULL
«	NULL
B	NULL
(	NULL
AMLT	NULL
}	NULL
,	NULL
and	NULL
B	NULL
genes	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Although	NULL
further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
determine	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
PEBP2	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
,	NULL
the	NULL
present	NULL
findings	NULL
suggested	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
relative	NULL
ratio	NULL
of	NULL
different	NULL
PEBP2	NULL
isoforms	NULL
in	NULL
regulating	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

within	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
is	NULL
quite	NULL
similar	NULL
to	NULL
that	NULL
within	NULL
the	NULL
A	NULL
core	NULL
of	NULL
the	NULL
Py	NULL
enhancer	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
function	NULL
of	NULL
PEBP2	NULL
as	NULL
a	NULL
potential	NULL
regulator	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
.	NULL

Purified	NULL
PEBP2	NULL
consists	NULL
of	NULL
a	NULL
and	NULL
3	NULL
subunits	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
'	NULL
We	NULL
have	NULL
identified	NULL
two	NULL
independent	NULL
genes	NULL
encoding	NULL
the	NULL
a	NULL
proteins	NULL
,	NULL
PEBP2aA®	NULL
``	NULL
and	NULL
PEBP2aB	NULL
,	NULL
``	NULL
``	NULL
and	NULL
a	NULL
single	NULL
gene	NULL
encoding	NULL
the	NULL
#	NULL
protein	NULL
.	NULL
``	NULL

The	NULL
a	NULL
proteins	NULL
contain	NULL
the	NULL
DNA-binding	NULL
domain	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
Drosophila	NULL
runt	NULL
protein	NULL
.	NULL
``	NULL

The	NULL
3	NULL
protein	NULL
can	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
by	NULL
itself	NULL
;	NULL
how-ever	NULL
,	NULL
its	NULL
association	NULL
with	NULL
the	NULL
a	NULL
protein	NULL
results	NULL
in	NULL
a	NULL
formation	NULL
of	NULL
a	NULL
heterodimeric	NULL
complex	NULL
with	NULL
an	NULL
increased	NULL
DNA-binding	NULL
affinity	NULL
.	NULL

``	NULL
``	NULL
``	NULL
*	NULL
>	NULL
``	NULL
We	NULL
recently	NULL
cloned	NULL
two	NULL
alternatively-spliced	NULL
aB	NULL
cDNA	NULL
species	NULL
encoding	NULL
two	NULL
distinct	NULL
isoforms	NULL
of	NULL
the	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
«	NULL
B1	NULL
and	NULL
«	NULL
B2	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

``	NULL
°	NULL
The	NULL
«	NULL
B2	NULL
protein	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
«	NULL
B1	NULL
protein	NULL
except	NULL
that	NULL
«	NULL
B2	NULL
has	NULL
an	NULL
internal	NULL
deletion	NULL
of	NULL
64	NULL
amino	NULL
acids	NULL
(	NULL
AaB2	NULL
)	NULL
.	NULL

These	NULL
two	NULL
isoforms	NULL
appear	NULL
to	NULL
have	NULL
distinct	NULL
functions	NULL
.	NULL
``	NULL

Recent	NULL
reports	NULL
suggest	NULL
remarkable	NULL
roles	NULL
of	NULL
PEBP2	NULL
in	NULL
leu-kemogenesis	NULL
.	NULL

The	NULL
human	NULL
homologue	NULL
of	NULL
PEBP2aB	NULL
is	NULL
AML1	NULL
,	NULL
which	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
the	NULL
breakpoints	NULL
on	NULL
chromosome	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Viral	NULL
Oncology	NULL
,	NULL
Institute	NULL
for	NULL
Virus	NULL
Research	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Kyoto	NULL
,	NULL
Japan	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
DNAX	NULL
Research	NULL
Institute	NULL
of	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Developmental	NULL
Biology	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
.	NULL

Submitted	NULL
May	NULL
13	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
March	NULL
5	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
Grant-in-Aid	NULL
for	NULL
Special	NULL
Project	NULL
Research	NULL
on	NULL
Cancer	NULL
Bio-Science	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
and	NULL
Culture	NULL
,	NULL
Japan	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Yoshiaki	NULL
Ito	NULL
,	NULL
MD	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Viral	NULL
Oncology	NULL
,	NULL
Institute	NULL
for	NULL
Virus	NULL
Research	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Shogoin	NULL
,	NULL
Sakyo-ku	NULL
,	NULL
Kyoto	NULL
606-01	NULL
,	NULL
Japan	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
'	NULL
``	NULL
'advertisement	NULL
``	NULL
'	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/95/8602-0036	NULL
$	NULL
3.00/0	NULL
607	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

608	NULL
A	NULL
~64	NULL
TAKAHASHI	NULL
ET	NULL
AL	NULL
cLEo	NULL
a	NULL
human	NULL
GM-CSF	NULL
mouse	NULL
GM-CSF	NULL
polyomavirus	NULL
5138	NULL
B	NULL
wt	NULL
GGAGTTCTGTGGTCACCATTACGC	NULL
61.62	NULL
sms	NULL
sms	NULL
1	NULL
mome	NULL
ases	NULL
sie	NULL
&	NULL
59.60	NULL
nme	NULL
ges	NULL
:	NULL
57	NULL
.	NULL

58	NULL
2a	NULL
a	NULL
nak	NULL
sax	NULL
seam	NULL
vGOk	NULL
s	NULL
see	NULL
new	NULL
®	NULL
21	NULL
of	NULL
8	NULL
;	NULL
21	NULL
and	NULL
3	NULL
;	NULL
21	NULL
translocations	NULL
observed	NULL
in	NULL
myeloid	NULL
leukemias	NULL
.	NULL

``	NULL
*	NULL
``	NULL
*	NULL
Also	NULL
,	NULL
the	NULL
human	NULL
homologue	NULL
of	NULL
PEBP23	NULL
has	NULL
been	NULL
identified	NULL
at	NULL
the	NULL
breakpoint	NULL
of	NULL
inversion	NULL
16	NULL
translocation	NULL
associated	NULL
with	NULL
a	NULL
subset	NULL
of	NULL
AML	NULL
.	NULL
``	NULL

PEBP2	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
T-cell-specific	NULL
gene	NULL
regulation	NULL
.	NULL

``	NULL
**	NULL
``	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
RNAs	NULL
obtained	NULL
from	NULL
mouse	NULL
tissues	NULL
and	NULL
in	NULL
situ	NULL
hybridization	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
tissue	NULL
sections	NULL
showed	NULL
that	NULL
PEBP2eA	NULL
and	NULL
aB	NULL
mRNAs	NULL
are	NULL
expressed	NULL
in	NULL
immature	NULL
and	NULL
mature	NULL
thymocytes	NULL
,	NULL
``	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
PEBP2	NULL
in	NULL
transcriptional	NULL
regulation	NULL
throughout	NULL
the	NULL
T-cell	NULL
development	NULL
.	NULL

The	NULL
potential	NULL
role	NULL
of	NULL
PEBP2	NULL
in	NULL
T-cell	NULL
ontogeny	NULL
has	NULL
been	NULL
suggested	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
TCR/	NULL
#	NULL
3	NULL
enhancer	NULL
by	NULL
exogenously	NULL
expressed	NULL
aAl	NULL
,	NULL
``	NULL
'	NULL
«	NULL
B1	NULL
,	NULL
or	NULL
«	NULL
B2	NULL
.	NULL

PEBP2	NULL
may	NULL
also	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
functions	NULL
of	NULL
mature	NULL
T	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
the	NULL
production	NULL
of	NULL
GM-CSF	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
exogenously	NULL
expressed	NULL
mouse	NULL
AMLI/PEBP2a	NULL
cDNAs	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
.	NULL

We	NULL
found	NULL
that	NULL
PEBP2	NULL
proteins	NULL
bind	NULL
the	NULL
PEBP	NULL
?	NULL

site	NULL
within	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
that	NULL
multiple	NULL
PEBP2	NULL
isoforms	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
positively	NULL
or	NULL
negatively	NULL
regulate	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
.	NULL

Runt	NULL
Nn	NULL
«	NULL
BIL	NULL
(	NULL
B2	NULL
Fig	NULL
2	NULL
.	NULL

A	NULL
diagrammatic	NULL
representation	NULL
of	NULL
mouse	NULL
PEBP2eA1	NULL
,	NULL
aB1	NULL
,	NULL
and	NULL
aB2	NULL
proteins	NULL
predicted	NULL
from	NULL
their	NULL
cDNA	NULL
sequences	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
Drosophila	NULL
runt	NULL
protein	NULL
is	NULL
also	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

Hatched	NULL
box	NULL
represents	NULL
the	NULL
Runt	NULL
domain	NULL
.	NULL

A	NULL
,	NULL
poly-alanine	NULL
stretch	NULL
;	NULL
Q	NULL
,	NULL
poly-glutamine	NULL
stretch	NULL
.	NULL

.	NULL

.	NULL

GGCATTTTGTGGTCACCATTAATCATTTCCTCTGTGT	NULL
..	NULL
.	NULL

.	NULL

GGAGTTOTGTGGTCACCATTAATCATTTCCTCTAACT	NULL
..	NULL
``	NULL
H	NULL
_	NULL
[	NULL
(	NULL
N	NULL
HI	NULL
.	NULL

.	NULL

-35	NULL
11	NULL
T_T	NULL
--	NULL
GTTAGTCACTTCCTGCTTAA	NULL
..	NULL

Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
comparison	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
regions	NULL
and	NULL
Py	NULL
enhancer	NULL
A	NULL
element	NULL
is	NULL
shown	NULL
.	NULL

PEBP2	NULL
consensus	NULL
sequences	NULL
are	NULL
boxed	NULL
.	NULL

CLEO	NULL
element	NULL
within	NULL
GM-CSF	NULL
promoter	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
ets	NULL
sites	NULL
within	NULL
Py	NULL
enhancer	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nucleotide	NULL
sequences	NULL
of	NULL
wt	NULL
and	NULL
mutant	NULL
forms	NULL
(	NULL
61.62	NULL
,	NULL
59.60	NULL
,	NULL
and	NULL
57.58	NULL
)	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
that	NULL
span	NULL
the	NULL
PEBP2	NULL
consensus	NULL
within	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
are	NULL
shown	NULL
.	NULL

Only	NULL
one	NULL
strand	NULL
is	NULL
represented	NULL
for	NULL
each	NULL
DNA	NULL
.	NULL

PEBP2	NULL
consensus	NULL
sequence	NULL
is	NULL
underlined	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

-	NULL
Wild-type	NULL
(	NULL
wt	NULL
;	NULL
pSVGM-95CAT	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
pSVGM-61.62CAT	NULL
)	NULL
reporter	NULL
plasmids	NULL
had	NULL
been	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
-95-to-+24	NULL
segment	NULL
of	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
into	NULL
the	NULL
pSVOCAT	NULL
plasmid	NULL
.	NULL
``	NULL

pEFBos-aA1	NULL
,	NULL
-a	NULL
«	NULL
B1	NULL
,	NULL
and	NULL
-a	NULL
«	NULL
B2	NULL
``	NULL
are	NULL
expression	NULL
plasmids	NULL
for	NULL
PEBP2aA1	NULL
,	NULL
«	NULL
B1	NULL
,	NULL
and	NULL
«	NULL
B2	NULL
cDNAs	NULL
driven	NULL
by	NULL
the	NULL
human	NULL
elongation	NULL
factor	NULL
1a	NULL
promoter	NULL
.	NULL
``	NULL

DNA-binding	NULL
assay	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
PEBP2aB1	NULL
and	NULL
«	NULL
B2	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

P19	NULL
mouse	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
were	NULL
maintained	NULL
and	NULL
transfected	NULL
with	NULL
pEFBos-aA	NULL
1	NULL
,	NULL
-	NULL
«	NULL
B1	NULL
,	NULL
and	NULL
-aB2	NULL
plasmids	NULL
as	NULL
described	NULL
.	NULL
``	NULL

In	NULL
brief	NULL
,	NULL
P19	NULL
cells	NULL
,	NULL
plated	NULL
at	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
6-cm	NULL
dish	NULL
24	NULL
hours	NULL
earlier	NULL
,	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
plasmid	NULL
DNAs	NULL
using	NULL
a	NULL
modified	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
procedure	NULL
``	NULL
``	NULL
and	NULL
were	NULL
harvested	NULL
48	NULL
hours	NULL
posttransfection	NULL
.	NULL

Jurkat	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
clone	NULL
JP1M1*	NULL
;	NULL
1	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
TPA	NULL
(	NULL
10	NULL
ng/mL	NULL
;	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
PHA	NULL
M-form	NULL
(	NULL
PHA-M	NULL
;	NULL
0.5	NULL
%	NULL
;	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
for	NULL
12	NULL
to	NULL
48	NULL
hours	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
10	NULL
%	NULL
FCS-RPMI	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
(	NULL
WCEs	NULL
)	NULL
of	NULL
P19	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
.	NULL
``	NULL

The	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
wt	NULL
PEBP2	NULL
consensus	NULL
sequence	NULL
was	NULL
either	NULL
radiolabeled	NULL
with	NULL
[	NULL
a-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
deoxycytidine	NULL
triphosphate	NULL
using	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
(	NULL
Toyobo	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
or	NULL
end-labeled	NULL
with	NULL
[	NULL
y-PJadenosine	NULL
triphosphate	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Toyobo	NULL
)	NULL
and	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

DNA-binding	NULL
reactions	NULL
and	NULL
electro-phoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
``	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

WCEs	NULL
(	NULL
10	NULL
to	NULL
20	NULL
g	NULL
)	NULL
or	NULL
in	NULL
vitro	NULL
translated	NULL
«	NULL
BI	NULL
or	NULL
«	NULL
B2	NULL
proteins	NULL
(	NULL
approximately	NULL
1	NULL
fmol	NULL
)	NULL
mixed	NULL
with	NULL
Escherichia	NULL
coli-produced	NULL
/32	NULL
protein	NULL
``	NULL
(	NULL
approximately	NULL
10	NULL
fmol	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
radiolabeled	NULL
DNA	NULL
probe	NULL
(	NULL
10°	NULL
cpm	NULL
)	NULL
in	NULL
a	NULL
10-uL	NULL
reaction	NULL
mix	NULL
containing	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mol/L	NULL
KCI	NULL
,	NULL
0.2	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.5	NULL
mmol/L	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
0.5	NULL
mmol/L	NULL
dithiothreitol	NULL
,	NULL
100	NULL
Lg/mL	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
0.01	NULL
%	NULL
Noni-det	NULL
P40	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
and	NULL
1	NULL
Lg	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

After	NULL
30	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
analyzed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
or	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
(	NULL
22	NULL
mmol/L	NULL
Tris	NULL
,	NULL
22	NULL
mmol/L	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
0.6	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
.	NULL

After	NULL
electrophoresis	NULL
at	NULL
350	NULL
V	NULL
(	NULL
10	NULL
to	NULL
30	NULL
mA	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
analyzed	NULL
by	NULL
image	NULL
analyzer	NULL
(	NULL
Fuji	NULL
Photo	NULL
Film	NULL
Co	NULL
,	NULL
Ltd	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Preparation	NULL
and	NULL
detailed	NULL
properties	NULL
of	NULL
the	NULL
anti-PEBP2aAl	NULL
rabbit	NULL
serum	NULL
used	NULL
in	NULL
antibody	NULL
supershift	NULL
experiments	NULL
are	NULL
described	NULL
elsewhere	NULL
.	NULL
``	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REGULATION	NULL
OF	NULL
GM-CSF	NULL
PROMOTER	NULL
BY	NULL
PEBP2	NULL
Transfection	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assay	NULL
.	NULL

A	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
and	NULL
an	NULL
effector	NULL
plasmid	NULL
(	NULL
0	NULL
to	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
``	NULL
``	NULL
(	NULL
2	NULL
to	NULL
5	NULL
x	NULL
10	NULL
®	NULL
cells	NULL
)	NULL
using	NULL
a	NULL
modified	NULL
diethyl	NULL
aminoethyl-dextran	NULL
method	NULL
.	NULL
``	NULL

After	NULL
24	NULL
hours	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
TPA	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
and	NULL
PHA-M	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
``	NULL
°	NULL
in	NULL
10	NULL
%	NULL
FCS-RPMI	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
extract	NULL
was	NULL
examined	NULL
at	NULL
48	NULL
hours	NULL
post-transfection	NULL
as	NULL
described	NULL
``	NULL
and	NULL
was	NULL
corrected	NULL
for	NULL
the	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
extract	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
kit	NULL
;	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Total	NULL
amount	NULL
of	NULL
plasmid	NULL
DNAs	NULL
transfected	NULL
was	NULL
adjusted	NULL
to	NULL
10	NULL
ug	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
pEF-Bos	NULL
backbone	NULL
vector	NULL
``	NULL
for	NULL
expression	NULL
plasmids	NULL
.	NULL

The	NULL
pRSV-BGal	NULL
plasmid	NULL
``	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
was	NULL
also	NULL
included	NULL
in	NULL
all	NULL
the	NULL
samples	NULL
to	NULL
monitor	NULL
the	NULL
efficiency	NULL
of	NULL
transfection	NULL
.	NULL

Northern	NULL
blotting	NULL
.	NULL

Total	NULL
cytoplasmic	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
unstimulated	NULL
-	NULL
and	NULL
-	NULL
TPA/PHA-stimulated	NULL
-	NULL
Jurkat	NULL
:	NULL
cells	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate/phenol-chloroform	NULL
extraction	NULL
procedure	NULL
.	NULL
``	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
selected	NULL
by	NULL
an	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
cellulose	NULL
column	NULL
(	NULL
Collabo-rative	NULL
Research	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
was	NULL
electrophoresed	NULL
in	NULL
a	NULL
formalde-hyde/1	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Hybond	NULL
N	NULL
;	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
and	NULL
fixed	NULL
by	NULL
UV-cross-linking	NULL
.	NULL

The	NULL
human	NULL
homologues	NULL
of	NULL
PEBP2aA	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
and	NULL
PEBP2/3	NULL
(	NULL
Oka	NULL
and	NULL
Ito	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
cDNAs	NULL
have	NULL
been	NULL
cloned	NULL
recently	NULL
from	NULL
a	NULL
human	NULL
T-cell	NULL
cDNA	NULL
li-brary	NULL
.	NULL

C6EGH2	NULL
probe	NULL
from	NULL
the	NULL
human	NULL
AMLZ	NULL
gene	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
M.	NULL
Ohki	NULL
,	NULL
National	NULL
Cancer	NULL
Center	NULL
Research	NULL
Institute	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
a	NULL
0.82-kb	NULL
HindIII-EcoRI	NULL
fragment	NULL
of	NULL
human	NULL
aA/	NULL
cDNA	NULL
,	NULL
and	NULL
a	NULL
Pvu	NULL
II-Pvu	NULL
II	NULL
fragment	NULL
of	NULL
human	NULL
PEBP232	NULL
cDNA	NULL
(	NULL
25	NULL
ng	NULL
each	NULL
)	NULL
were	NULL
P-labeled	NULL
by	NULL
a	NULL
random	NULL
priming	NULL
method	NULL
(	NULL
Multiprime	NULL
labeling	NULL
kit	NULL
;	NULL
Amersham	NULL
)	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

Hybridization	NULL
and	NULL
washing	NULL
of	NULL
the	NULL
blots	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
a	NULL
phosphate	NULL
buffer	NULL
method	NULL
``	NULL
``	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
the	NULL
nylon	NULL
membrane	NULL
was	NULL
prehybridized	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
hybridization	NULL
Fig	NULL
3	NULL
.	NULL

Binding	NULL
of	NULL
mouse	NULL
PEBP2	NULL
«	NULL
proteins	NULL
to	NULL
PEBP2	NULL
site	NULL
within	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

Wt	NULL
oligonucleotide	NULL
from	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
Fig	NULL
1B	NULL
,	NULL
wt	NULL
)	NULL
,	NULL
*	NULL
P-labeled	NULL
by	NULL
Klenow	NULL
enzyme	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

PEBP2aB1	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
and	NULL
«	NULL
B2	NULL
proteins	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
10	NULL
)	NULL
were	NULL
translated	NULL
in	NULL
vitro	NULL
and	NULL
mixed	NULL
with	NULL
PEBP22	NULL
protein	NULL
expressed	NULL
in	NULL
E	NULL
coli	NULL
.	NULL

PEBP2	NULL
«	NULL
A1	NULL
protein	NULL
was	NULL
overexpressed	NULL
in	NULL
P19	NULL
cells	NULL
,	NULL
and	NULL
their	NULL
WCE	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
used	NULL
(	NULL
lanes	NULL
11	NULL
to	NULL
14	NULL
)	NULL
.	NULL

WCE	NULL
was	NULL
also	NULL
obtained	NULL
from	NULL
P19	NULL
cells	NULL
transfected	NULL
with	NULL
backbone	NULL
vector	NULL
for	NULL
expression	NULL
plasmids	NULL
(	NULL
pEF-Bos	NULL
;	NULL
lane	NULL
15	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
using	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

(	NULL
-	NULL
)	NULL
,	NULL
no	NULL
competitor	NULL
added	NULL
;	NULL
wt	NULL
,	NULL
61.62	NULL
,	NULL
59.60	NULL
,	NULL
a	NULL
66-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
added	NULL
as	NULL
competitors	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
,	NULL
8	NULL
to	NULL
10	NULL
,	NULL
and	NULL
12	NULL
to	NULL
14	NULL
)	NULL
.	NULL

Reaction	NULL
mixture	NULL
using	NULL
WCE	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
of	NULL
Jurkat	NULL
cells	NULL
that	NULL
were	NULL
unstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
TPA/PHA-stimulated	NULL
for	NULL
12	NULL
hours	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
electrophoresed	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
for	NULL
comparison	NULL
.	NULL

The	NULL
arrows	NULL
on	NULL
the	NULL
left	NULL
denote	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
specific	NULL
complexes	NULL
corresponding	NULL
to	NULL
PEBP2	NULL
binding	NULL
.	NULL

609	NULL
buffer	NULL
containing	NULL
0.5	NULL
mol/L	NULL
Na	NULL
;	NULL
,	NULL
HPO	NULL
,	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
7	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
and	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
sealable	NULL
bag	NULL
containing	NULL
the	NULL
hybridization	NULL
buffer	NULL
and	NULL
a	NULL
radiolabeled	NULL
probe	NULL
.	NULL

After	NULL
overnight	NULL
hybridization	NULL
at	NULL
65°C	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
washed	NULL
for	NULL
5	NULL
minutes	NULL
3	NULL
times	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
for	NULL
30	NULL
minutes	NULL
once	NULL
at	NULL
65°C	NULL
in	NULL
a	NULL
washing	NULL
buffer	NULL
containing	NULL
40	NULL
mmol/L	NULL
Na	NULL
;	NULL
HPO	NULL
,	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
and	NULL
1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
.	NULL

After	NULL
exposure	NULL
to	NULL
x-ray	NULL
films	NULL
,	NULL
all	NULL
the	NULL
membranes	NULL
were	NULL
washed	NULL
to	NULL
strip	NULL
off	NULL
radioactivities	NULL
and	NULL
were	NULL
reprobed	NULL
with	NULL
human	NULL
3-actin	NULL
cDNA	NULL
to	NULL
assess	NULL
the	NULL
integrity	NULL
and	NULL
quantity	NULL
of	NULL
the	NULL
loaded	NULL
RNA	NULL
.	NULL

RESULTS	NULL
Binding	NULL
of	NULL
PEBP2	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

We	NULL
first	NULL
examined	NULL
by	NULL
EMSA	NULL
whether	NULL
the	NULL
mouse	NULL
PEBP2	NULL
proteins	NULL
bind	NULL
the	NULL
PEBP2	NULL
consensus	NULL
sequence	NULL
within	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
encompassing	NULL
nucleotides	NULL
-71	NULL
to	NULL
-51	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
their	NULL
mutants	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
1B	NULL
)	NULL
were	NULL
used	NULL
as	NULL
labeled	NULL
probes	NULL
or	NULL
competitors	NULL
.	NULL

PEBP2	NULL
«	NULL
B1	NULL
and	NULL
«	NULL
B2	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
were	NULL
translated	NULL
in	NULL
vitro	NULL
and	NULL
mixed	NULL
with	NULL
32	NULL
protein	NULL
,	NULL
the	NULL
most	NULL
abundant	NULL
isoform	NULL
encoded	NULL
by	NULL
the	NULL
/3	NULL
gene	NULL
,	NULL
which	NULL
had	NULL
been	NULL
expressed	NULL
in	NULL
E	NULL
coli	NULL
and	NULL
purified	NULL
.	NULL
``	NULL

Figure	NULL
3	NULL
shows	NULL
an	NULL
EMSA	NULL
pattern	NULL
obtained	NULL
using	NULL
radiolabeled	NULL
wt	NULL
oligonucleotides	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

A	NULL
single	NULL
major	NULL
protein-DNA	NULL
complex	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
«	NULL
BI	NULL
and	NULL
32	NULL
proteins	NULL
were	NULL
mixed	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

WCEs	NULL
of	NULL
aB	NULL
!	NULL

l-transfected	NULL
P19	NULL
cells	NULL
created	NULL
a	NULL
complex	NULL
that	NULL
comigrated	NULL
with	NULL
it	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

«	NULL
B1	NULL
alone	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
B2	NULL
created	NULL
a	NULL
faster-migrating	NULL
and	NULL
less	NULL
dense	NULL
band	NULL
as	NULL
observed	NULL
before	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

``	NULL
°	NULL
Sequence	NULL
specificity	NULL
of	NULL
the	NULL
binding	NULL
was	NULL
assessed	NULL
by	NULL
adding	NULL
66-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
wt	NULL
or	NULL
mutant	NULL
oligonucleotide	NULL
competitors	NULL
.	NULL

The	NULL
com	NULL
L	NULL
O	NULL
3	NULL
G	NULL
€	NULL
5	NULL
P19	NULL
WCE	NULL
3	NULL
p4	NULL
aB1+B2	NULL
_	NULL
aB2+B2	NULL
CA1	NULL
(	NULL
-	NULL
)	NULL
8	NULL
<	NULL
2	NULL
C	NULL
E	NULL
a	NULL
=	NULL
=	NULL
«	NULL
o	NULL
a	NULL
o	NULL
a	NULL
o	NULL
a	NULL
<	NULL
w	NULL
o	NULL
«	NULL
©	NULL
o	NULL
«	NULL
©	NULL
3	NULL
5	NULL
£	NULL
.	NULL

t	NULL
5	NULL
§	NULL
.	NULL

E	NULL
5	NULL
§	NULL
.	NULL

$	NULL
5	NULL
8	NULL
+	NULL
.	NULL

competitor	NULL
e	NULL
de	NULL
fie	NULL
6	NULL
boo	NULL
bot	NULL
but	NULL
to	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

610	NULL
plex	NULL
formation	NULL
was	NULL
abolished	NULL
by	NULL
the	NULL
wt	NULL
competitor	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
61.62	NULL
or	NULL
59.60	NULL
mutants	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
B2	NULL
protein	NULL
formed	NULL
a	NULL
faster-migrating	NULL
complex	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
mutant	NULL
competitors	NULL
,	NULL
61.62	NULL
and	NULL
59.60	NULL
,	NULL
weakly	NULL
competed	NULL
with	NULL
the	NULL
band	NULL
formation	NULL
(	NULL
see	NULL
Fig	NULL
3	NULL
and	NULL
compare	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
with	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

This	NULL
is	NULL
most	NULL
likely	NULL
because	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
«	NULL
B2	NULL
binds	NULL
to	NULL
DNA	NULL
2	NULL
to	NULL
3	NULL
times	NULL
more	NULL
strongly	NULL
than	NULL
aBI1*	NULL
``	NULL
and	NULL
that	NULL
each	NULL
of	NULL
these	NULL
two	NULL
mutations	NULL
did	NULL
not	NULL
completely	NULL
abolish	NULL
the	NULL
binding	NULL
site	NULL
.	NULL

PEBP2aA	NULL
!	NULL

(	NULL
Fig	NULL
2	NULL
)	NULL
cDNA	NULL
was	NULL
transfected	NULL
into	NULL
P19	NULL
cells	NULL
that	NULL
express	NULL
neither	NULL
aA	NULL
nor	NULL
aB	NULL
,	NULL
and	NULL
their	NULL
WCE	NULL
was	NULL
prepared	NULL
.	NULL

«	NULL
A1	NULL
protein	NULL
also	NULL
generated	NULL
a	NULL
complex	NULL
having	NULL
similar	NULL
PEBP2	NULL
site-binding	NULL
property	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
14	NULL
)	NULL
.	NULL

It	NULL
migrated	NULL
more	NULL
slowly	NULL
than	NULL
the	NULL
complex	NULL
formed	NULL
by	NULL
the	NULL
«	NULL
BI	NULL
and	NULL
32	NULL
proteins	NULL
.	NULL

A	NULL
faster-migrating	NULL
doublet	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
which	NULL
migrated	NULL
at	NULL
about	NULL
the	NULL
same	NULL
position	NULL
as	NULL
«	NULL
B2	NULL
and	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
WCE	NULL
from	NULL
P19	NULL
cells	NULL
not	NULL
transfected	NULL
with	NULL
PEBP2a	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
15	NULL
)	NULL
,	NULL
did	NULL
not	NULL
show	NULL
PEBP2-site	NULL
specificity	NULL
(	NULL
see	NULL
Fig	NULL
3	NULL
and	NULL
compare	NULL
lanes	NULL
12	NULL
,	NULL
13	NULL
,	NULL
and	NULL
14	NULL
with	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
doublet	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
doublet	NULL
was	NULL
reduced	NULL
after	NULL
the	NULL
TPA/PHA	NULL
stimulation	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
we	NULL
rigorously	NULL
examined	NULL
whether	NULL
they	NULL
are	NULL
related	NULL
to	NULL
PEBP2	NULL
.	NULL

By	NULL
performing	NULL
EMSA	NULL
using	NULL
the	NULL
oligonucleotides	NULL
as	NULL
probes	NULL
or	NULL
competitors	NULL
containing	NULL
the	NULL
consensus	NULL
PEBP2	NULL
site	NULL
as	NULL
well	NULL
as	NULL
mutated	NULL
versions	NULL
,	NULL
including	NULL
the	NULL
one	NULL
harboring	NULL
the	NULL
completely	NULL
mutated	NULL
PEBP2	NULL
site	NULL
(	NULL
GTGCCAG	NULL
compared	NULL
with	NULL
the	NULL
original	NULL
TGTGGTC	NULL
)	NULL
,	NULL
and	NULL
by	NULL
testing	NULL
the	NULL
reactivity	NULL
of	NULL
the	NULL
anti-eAl	NULL
antiserum	NULL
,	NULL
``	NULL
``	NULL
we	NULL
came	NULL
to	NULL
the	NULL
conclusion	NULL
that	NULL
they	NULL
are	NULL
unrelated	NULL
to	NULL
PEBP2	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
represent	NULL
nonspecific	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
PEBP2	NULL
«	NULL
B1	NULL
,	NULL
«	NULL
B2	NULL
,	NULL
and	NULL
«	NULL
A1	NULL
proteins	NULL
bind	NULL
the	NULL
PEBP2	NULL
site	NULL
within	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
at	NULL
least	NULL
in	NULL
vitro	NULL
,	NULL
most	NULL
likely	NULL
as	NULL
a	NULL
heterodimer	NULL
with	NULL
the	NULL
/3	NULL
protein	NULL
.	NULL

Effect	NULL
of	NULL
PEBP2	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
.	NULL

pSVGM-95CAT	NULL
reporter	NULL
plasmid	NULL
encodes	NULL
the	NULL
CAT	NULL
gene	NULL
driven	NULL
by	NULL
nucleotides	NULL
-95	NULL
to	NULL
+24	NULL
of	NULL
the	NULL
mouse	NULL
GM-CSF	NULL
promoter	NULL
region	NULL
containing	NULL
CLEZ/CK-2	NULL
,	NULL
``	NULL
~*	NULL
``	NULL
°	NULL
GM-	NULL
«	NULL
kB	NULL
,	NULL
``	NULL
52	NULL
``	NULL
'	NULL
GC	NULL
box	NULL
,	NULL
``	NULL
``	NULL
PEBP2	NULL
consensus	NULL
,	NULL
CATT	NULL
(	NULL
A/T	NULL
)	NULL
repeat	NULL
,	NULL
``	NULL
and	NULL
CLEO'*	NULL
``	NULL
elements	NULL
.	NULL

The	NULL
pSVGM-95CAT	NULL
was	NULL
cotransfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
PEBP2aA1	NULL
,	NULL
«	NULL
B1	NULL
,	NULL
or	NULL
«	NULL
B2	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TPA/PHA	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4A	NULL
,	NULL
expression	NULL
of	NULL
«	NULL
A1	NULL
or	NULL
«	NULL
B1	NULL
stimulated	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
«	NULL
B2	NULL
inhibited	NULL
the	NULL
promoter	NULL
activity	NULL
by	NULL
about	NULL
50	NULL
%	NULL
in	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
.	NULL

The	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
effector	NULL
plasmids	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
TPA/PHA	NULL
treatment	NULL
as	NULL
assessed	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
pEFBos-CAT	NULL
in	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
PEBP2	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
were	NULL
mediated	NULL
by	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
PEBP2	NULL
site	NULL
,	NULL
the	NULL
61.62	NULL
mutation	NULL
in	NULL
Fig	NULL
1B	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
CAT	NULL
plasmid	NULL
.	NULL

The	NULL
«	NULL
A1	NULL
and	NULL
«	NULL
B1	NULL
failed	NULL
to	NULL
activate	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
mutant	NULL
pSVGM61.62CAT	NULL
plasmid	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
repression	NULL
by	NULL
the	NULL
«	NULL
B2	NULL
was	NULL
also	NULL
abolished	NULL
by	NULL
the	NULL
mutation	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
PEBP2	NULL
regulates	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
,	NULL
positively	NULL
or	NULL
negatively	NULL
depending	NULL
on	NULL
its	NULL
isoforms	NULL
,	NULL
by	NULL
binding	NULL
to	NULL
its	NULL
cognate	NULL
binding	NULL
site	NULL
in	NULL
vivo	NULL
.	NULL

TAKAHASHI	NULL
ET	NULL
AL	NULL
15	NULL
l	NULL
-B-	NULL
oA1	NULL
-*-	NULL
aBi	NULL
:	NULL
|	NULL
TPA/PHA	NULL
>	NULL
-*-	NULL
«	NULL
B2	NULL
>	NULL
10	NULL
-O-	NULL
aA1	NULL
B	NULL
-o-	NULL
aB1	NULL
J	NULL
unstimulated	NULL
i-	NULL
-A-	NULL
aB2	NULL
<	NULL
4	NULL
o	NULL
@	NULL
€	NULL
5	NULL
S	NULL
@	NULL
CC	NULL
0	NULL
v	NULL
7	NULL
0	NULL
1	NULL
5	NULL
A	NULL
.	NULL

effector	NULL
plasmid	NULL
(	NULL
ug	NULL
)	NULL
15	NULL
>	NULL
is	NULL
10	NULL
4	NULL
8	NULL
-	NULL
|	NULL
o	NULL
(	NULL
)	NULL
l	NULL
;	NULL
|	NULL
©	NULL
oA	NULL
o	NULL
-	NULL
E	NULL
cBi	NULL
g	NULL
B	NULL
OQ	NULL
«	NULL
B2	NULL
I	NULL
ol	NULL
C	NULL
0	NULL
4	NULL
wt	NULL
61.62	NULL
wt	NULL
61.62	NULL
B	NULL
I.	NULL
L	NULL
_c	NULL
}	NULL
TPA/PHA	NULL
unstimulated	NULL
Fig	NULL
4	NULL
.	NULL

Effects	NULL
of	NULL
PEBP2	NULL
«	NULL
proteins	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
indicated	NULL
amount	NULL
of	NULL
expression	NULL
plasmids	NULL
encoding	NULL
PEBP2	NULL
«	NULL
A1	NULL
,	NULL
aB1	NULL
,	NULL
or	NULL
«	NULL
B2	NULL
proteins	NULL
together	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter-CAT	NULL
plasmid	NULL
(	NULL
pSVGM-95CAT	NULL
)	NULL
}	NULL
.	NULL

After	NULL
24	NULL
hours	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TPA	NULL
and	NULL
PHA	NULL
or	NULL
left	NULL
unstimulated	NULL
for	NULL
additional	NULL
24	NULL
hours	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
that	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
not	NULL
transfected	NULL
with	NULL
PEB-P2	NULL
«	NULL
s	NULL
.	NULL

Each	NULL
point	NULL
represents	NULL
an	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
transfec-tions	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
mutations	NULL
in	NULL
PEBP2	NULL
site	NULL
within	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
each	NULL
expression	NULL
(	NULL
«	NULL
A1	NULL
,	NULL
«	NULL
B1	NULL
,	NULL
«	NULL
B2	NULL
)	NULL
or	NULL
backbone	NULL
(	NULL
-	NULL
)	NULL
vector	NULL
and	NULL
4	NULL
ug	NULL
of	NULL
wt	NULL
(	NULL
pSVGM-95CAT	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
61.62	NULL
;	NULL
pSVGM61.62CAT	NULL
)	NULL
reporter	NULL
CAT	NULL
plasmid	NULL
.	NULL

Averages	NULL
of	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
opposite	NULL
effects	NULL
of	NULL
«	NULL
BI	NULL
and	NULL
«	NULL
B2	NULL
prompted	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
possibility	NULL
that	NULL
they	NULL
can	NULL
antagonize	NULL
with	NULL
each	NULL
other	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

«	NULL
BI	NULL
and	NULL
aB2	NULL
were	NULL
cotransfected	NULL
at	NULL
various	NULL
ratios	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

As	NULL
the	NULL
«	NULL
B1/	NULL
«	NULL
B2	NULL
ratio	NULL
increased	NULL
,	NULL
there	NULL
was	NULL
a	NULL
gradual	NULL
increase	NULL
in	NULL
the	NULL
CAT	NULL
activity	NULL
in	NULL
both	NULL
TPA/PHA-stimulated	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
and	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggested	NULL
that	NULL
there	NULL
is	NULL
a	NULL
regulatory	NULL
mechanism	NULL
that	NULL
involves	NULL
the	NULL
competition	NULL
among	NULL
PEBP2	NULL
«	NULL
proteins	NULL
with	NULL
distinct	NULL
transactivation	NULL
or	NULL
repression	NULL
potentials	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

Expression	NULL
of	NULL
PEBP2	NULL
site-binding	NULL
proteins	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

When	NULL
WCE	NULL
of	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
labeled	NULL
GM-CSF	NULL
promoter	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
1B	NULL
,	NULL
wt	NULL
)	NULL
,	NULL
two	NULL
major	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
ob-served	NULL
,	NULL
the	NULL
faster-migrating	NULL
one	NULL
being	NULL
a	NULL
doublet	NULL
as	NULL
described	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REGULATION	NULL
OF	NULL
GM-CSF	NULL
PROMOTER	NULL
BY	NULL
PEBP2	NULL
Fig	NULL
5	NULL
.	NULL

Effect	NULL
of	NULL
cotransfection	NULL
of	NULL
PEBP2	NULL
«	NULL
B1	NULL
and	NULL
aB2	NULL
at	NULL
various	NULL
ratios	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
.	NULL

Jurkat	NULL
cells	NULL
(	NULL
4.5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
indicated	NULL
amounts	NULL
of	NULL
pEFBos-aB1	NULL
and	NULL
-aB2	NULL
expression	NULL
plasmids	NULL
together	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
pSVGM-95CAT	NULL
and	NULL
were	NULL
TPA/PHA-stimulated	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
assayed	NULL
using	NULL
one	NULL
oo	NULL
.	NULL

‘	NULL
mac	NULL
.	NULL

sixth	NULL
of	NULL
the	NULL
cell	NULL
extracts	NULL
.	NULL

The	NULL
yB1	NULL
value	NULL
for	NULL
percentage	NULL
of	NULL
chloram-henicol	NULL
acetylation	NULL
is	NULL
shown	NULL
s	NULL
lke	NULL
cB2	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

above	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
the	NULL
slower-migrating	NULL
complex	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
was	NULL
abolished	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
unlabeled	NULL
wt	NULL
oligonucleotides	NULL
in	NULL
the	NULL
reaction	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
competitors	NULL
containing	NULL
mutated	NULL
PEBP2	NULL
sites	NULL
,	NULL
61.62	NULL
and	NULL
59.60	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
57.58	NULL
,	NULL
located	NULL
at	NULL
the	NULL
margin	NULL
of	NULL
the	NULL
PEBP2	NULL
site	NULL
,	NULL
partially	NULL
inhibited	NULL
the	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
complex	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
showed	NULL
the	NULL
property	NULL
of	NULL
a	NULL
PEBP2	NULL
site-specific	NULL
protein-DNA	NULL
complex	NULL
.	NULL

The	NULL
faster-migrating	NULL
doublet	NULL
was	NULL
considered	NULL
nonspecific	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

When	NULL
the	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TPA/PHA	NULL
for	NULL
24	NULL
or	NULL
48	NULL
hours	NULL
,	NULL
the	NULL
specific	NULL
band	NULL
was	NULL
also	NULL
detected	NULL
,	NULL
but	NULL
its	NULL
intensity	NULL
was	NULL
slightly	NULL
diminished	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
gel-shift	NULL
mobility	NULL
showed	NULL
that	NULL
the	NULL
Jurkat	NULL
complex	NULL
comigrated	NULL
with	NULL
the	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
by	NULL
the	NULL
mixture	NULL
of	NULL
the	NULL
mouse	NULL
aBI1	NULL
and	NULL
B2	NULL
proteins	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
the	NULL
presence	NULL
of	NULL
endogenous	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
PEBP2	NULL
site	NULL
within	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
unstimulated	NULL
and	NULL
TPA/	NULL
PHA-stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
PEBP2a	NULL
proteins	NULL
,	NULL
when	NULL
exogenously	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
could	NULL
compete	NULL
with	NULL
the	NULL
endogenous	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
WCE	NULL
of	NULL
PEBP2aA1l-overexpressed	NULL
P19	NULL
cells	NULL
was	NULL
mixed	NULL
with	NULL
Jurkat	NULL
WCE	NULL
in	NULL
EMSA	NULL
.	NULL

As	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
«	NULL
Al-containing	NULL
extract	NULL
was	NULL
increased	NULL
,	NULL
the	NULL
Jurkat	NULL
complex	NULL
gradually	NULL
decreased	NULL
in	NULL
amount	NULL
,	NULL
and	NULL
the	NULL
«	NULL
A1	NULL
band	NULL
increased	NULL
in	NULL
intensity	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
«	NULL
B2-containing	NULL
extract	NULL
also	NULL
gave	NULL
a	NULL
similar	NULL
result	NULL
(	NULL
Fig	NULL
7B	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
.	NULL

The	NULL
Jurkat	NULL
complex	NULL
was	NULL
not	NULL
diminished	NULL
by	NULL
addition	NULL
of	NULL
WCE	NULL
from	NULL
P19	NULL
cells	NULL
transfected	NULL
with	NULL
pEF-Bos	NULL
backbone	NULL
vector	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
established	NULL
that	NULL
there	NULL
are	NULL
endogenous	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
have	NULL
the	NULL
DNA-binding	NULL
properties	NULL
similar	NULL
to	NULL
«	NULL
Al	NULL
and	NULL
«	NULL
B2	NULL
.	NULL

These	NULL
results	NULL
also	NULL
suggested	NULL
that	NULL
«	NULL
A1	NULL
,	NULL
«	NULL
B1	NULL
,	NULL
and	NULL
«	NULL
B2	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
exerted	NULL
their	NULL
transcriptional	NULL
regulatory	NULL
activity	NULL
by	NULL
competing	NULL
with	NULL
endogenous	NULL
Jurkat	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
reactivity	NULL
of	NULL
the	NULL
Jurkat	NULL
complex	NULL
to	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
against	NULL
mouse	NULL
«	NULL
Al	NULL
protein	NULL
,	NULL
which	NULL
also	NULL
cross-reacts	NULL
with	NULL
mouse	NULL
B1	NULL
.	NULL
``	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
611	NULL
15.2	NULL
-	NULL
22.3	NULL
-	NULL
30.0	NULL
37.2	NULL
49.4	NULL
(	NULL
%	NULL
)	NULL
o	NULL
eo	NULL
O0	NULL
O0	NULL
0	NULL
«	NULL
«	NULL
io	NULL
o	NULL
o	NULL
O0	NULL
O0	NULL
O0	NULL
_	NULL
e	NULL
@	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
4	NULL
3	NULL
2	NULL
1	NULL
0	NULL
-	NULL
(	NULL
ug	NULL
)	NULL
<	NULL
T	NULL
a	NULL
.	NULL

<	NULL
a.	NULL
unstimulated	NULL
&	NULL
L	NULL
&	NULL
a	NULL
$	NULL
61.62	NULL
59.60	NULL
57.58	NULL
competitor	NULL
-	NULL
.	NULL

H3	NULL
&	NULL
u	NULL
(	NULL
TCE	NULL
-	NULL
CC	NULL
[	NULL
3	NULL
#	NULL
&	NULL
4	NULL
&	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fig	NULL
6	NULL
.	NULL

Detection	NULL
of	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
within	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

WCE	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
,	NULL
unstimulated	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
or	NULL
TPA/PHA-stimulated	NULL
for	NULL
24	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
48	NULL
hours	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
containing	NULL
end-labeled	NULL
wt	NULL
probe	NULL
.	NULL

A	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
indicated	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
were	NULL
added	NULL
as	NULL
competitors	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
electrophoresis	NULL
.	NULL

The	NULL
PEBP2	NULL
site-specific	NULL
protein-DNA	NULL
complex	NULL
is	NULL
indicate	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

612	NULL
A	NULL
cA1	NULL
_	NULL
5	NULL
10	NULL
20	NULL
30	NULL
20	NULL
Jurkat	NULL
WCE	NULL
10	NULL
10	NULL
10	NULL
10	NULL
10	NULL
-	NULL
10	NULL
(	NULL
ug	NULL
)	NULL
Jurkat	NULL
PEGD2	NULL
-	NULL
ve	NULL
tof	NULL
W	NULL
u	NULL
u	NULL
H	NULL
be	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
TAKAHASHI	NULL
ET	NULL
AL	NULL
5	NULL
10	NULL
20	NULL
30	NULL
20	NULL
B	NULL
«	NULL
B2	NULL
Jurkat	NULL
WCE	NULL
10	NULL
10	NULL
10	NULL
10	NULL
10	NULL
-	NULL
(	NULL
ug	NULL
)	NULL
Jurkat	NULL
PEBP2	NULL
-	NULL
>	NULL
eB2	NULL
-	NULL
>	NULL
i	NULL
~	NULL
a	NULL
a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
7	NULL
.	NULL

Displacement	NULL
of	NULL
Jurkat	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
by	NULL
mouse	NULL
PEBP2	NULL
«	NULL
A1	NULL
and	NULL
aB2	NULL
proteins	NULL
.	NULL

An	NULL
indicated	NULL
amount	NULL
of	NULL
WCE	NULL
from	NULL
P19	NULL
cells	NULL
transfected	NULL
with	NULL
PEBP2	NULL
«	NULL
A1	NULL
(	NULL
A	NULL
)	NULL
or	NULL
PEBP2	NULL
«	NULL
B2	NULL
(	NULL
B	NULL
)	NULL
,	NULL
alone	NULL
or	NULL
mixed	NULL
with	NULL
WCE	NULL
from	NULL
Jurkat	NULL
cells	NULL
TPA/PHA-stimulated	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
end-labeled	NULL
wt	NULL
probe	NULL
and	NULL
electrophoresed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Arrows	NULL
on	NULL
the	NULL
left	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
PEBP2	NULL
«	NULL
A1-	NULL
(	NULL
A	NULL
)	NULL
or	NULL
aB2-	NULL
(	NULL
B	NULL
)	NULL
containing	NULL
complex	NULL
and	NULL
Jurkat	NULL
PEBP2	NULL
site-specific	NULL
protein-DNA	NULL
complex	NULL
.	NULL

antiserum	NULL
induced	NULL
the	NULL
supershift	NULL
of	NULL
the	NULL
authentic	NULL
mouse	NULL
«	NULL
Al-	NULL
or	NULL
a	NULL
«	NULL
B1-containing	NULL
protein-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
antiserum	NULL
,	NULL
but	NULL
not	NULL
the	NULL
preimmune	NULL
serum	NULL
,	NULL
caused	NULL
the	NULL
supershift	NULL
of	NULL
the	NULL
Jurkat	NULL
complex	NULL
formed	NULL
by	NULL
WCE	NULL
of	NULL
unstimulated	NULL
or	NULL
TPA/PHA-stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
8	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
the	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
present	NULL
in	NULL
Jurkat	NULL
cells	NULL
are	NULL
antigenically	NULL
related	NULL
to	NULL
the	NULL
mouse	NULL
PEBP2a	NULL
«	NULL
A1	NULL
and	NULL
aBI1	NULL
proteins	NULL
.	NULL

The	NULL
faster-migrating	NULL
bands	NULL
in	NULL
Fig	NULL
8	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
,	NULL
did	NULL
not	NULL
react	NULL
with	NULL
the	NULL
antiserum	NULL
.	NULL

Therefore	NULL
,	NULL
they	NULL
were	NULL
considered	NULL
nonspe-cific	NULL
.	NULL

PEBP2aA	NULL
,	NULL
«	NULL
B	NULL
,	NULL
and	NULL
B	NULL
mRNA	NULL
expression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

EMSA	NULL
showed	NULL
that	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
structurally	NULL
related	NULL
to	NULL
mouse	NULL
PEBP2	NULL
«	NULL
@	NULL
proteins	NULL
were	NULL
present	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blot	NULL
analysis	NULL
to	NULL
examine	NULL
the	NULL
expression	NULL
of	NULL
human	NULL
PEBP2	NULL
genes	NULL
.	NULL

The	NULL
human	NULL
e	NULL
«	NULL
B/AMLI	NULL
probe	NULL
showed	NULL
at	NULL
least	NULL
four	NULL
major	NULL
species	NULL
of	NULL
mRNA	NULL
(	NULL
Fig	NULL
9	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
similar	NULL
to	NULL
those	NULL
described	NULL
for	NULL
human	NULL
peripheral	NULL
blood	NULL
cells	NULL
.	NULL

``	NULL
°	NULL
After	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TPA/PHA	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
human	NULL
«	NULL
B/	NULL
AMLLI	NULL
was	NULL
markedly	NULL
downregulated	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
aA	NULL
mRNA	NULL
,	NULL
increased	NULL
amounts	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
had	NULL
to	NULL
be	NULL
blotted	NULL
to	NULL
detect	NULL
the	NULL
signals	NULL
,	NULL
suggesting	NULL
that	NULL
its	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
much	NULL
less	NULL
than	NULL
that	NULL
of	NULL
human	NULL
«	NULL
BI/AMLI	NULL
.	NULL

The	NULL
human	NULL
«	NULL
A	NULL
probe	NULL
showed	NULL
a	NULL
cluster	NULL
of	NULL
three	NULL
major	NULL
mRNA	NULL
species	NULL
of	NULL
7.1	NULL
,	NULL
6.7	NULL
,	NULL
and	NULL
6.1	NULL
kb	NULL
(	NULL
Fig	NULL
9	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
human	NULL
aA	NULL
mRNA	NULL
was	NULL
also	NULL
markedly	NULL
decreased	NULL
in	NULL
TPA/PHA-stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

A	NULL
single	NULL
major	NULL
species	NULL
of	NULL
the	NULL
human	NULL
PEB-P2GmRNA	NULL
was	NULL
detected	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
9	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
TPA/PHA	NULL
stimulation	NULL
significantly	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
the	NULL
human	NULL
PEBP23	NULL
expression	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
human	NULL
homologue	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
aB	NULL
and	NULL
possibly	NULL
«	NULL
A	NULL
proteins	NULL
constitutes	NULL
at	NULL
least	NULL
a	NULL
part	NULL
of	NULL
the	NULL
Jurkat	NULL
complex	NULL
shown	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
biologic	NULL
significance	NULL
of	NULL
the	NULL
TPA/PHA-induced	NULL
downregulation	NULL
of	NULL
aA	NULL
,	NULL
eB/AML1	NULL
,	NULL
and	NULL
3	NULL
expression	NULL
remains	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

DISCUSSION	NULL
Sequence	NULL
analysis	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
had	NULL
shown	NULL
a	NULL
putative	NULL
binding	NULL
site	NULL
for	NULL
PEBP2	NULL
that	NULL
is	NULL
totally	NULL
conserved	NULL
between	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
human	NULL
genes	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
PEBP2	NULL
indeed	NULL
binds	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
that	NULL
the	NULL
exogenously	NULL
expressed	NULL
«	NULL
A1	NULL
and	NULL
«	NULL
BI	NULL
activate	NULL
and	NULL
«	NULL
B2	NULL
in-hibits	NULL
,	NULL
through	NULL
the	NULL
PEBP2	NULL
site	NULL
,	NULL
the	NULL
transcription	NULL
from	NULL
the	NULL
transfected	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

Human	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
expresses	NULL
low	NULL
levels	NULL
of	NULL
aA	NULL
and	NULL
much	NULL
higher	NULL
levels	NULL
of	NULL
aB	NULL
mRNAs	NULL
.	NULL

By	NULL
EMSA	NULL
,	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
was	NULL
de	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REGULATION	NULL
OF	NULL
GM-CSF	NULL
PROMOTER	NULL
BY	NULL
PEBP2	NULL
Jurkat	NULL
|	NULL
aA1	NULL
oBi	NULL
I	NULL
unstimulated	NULL
I	NULL
TPA/PHA	NULL
Pre	NULL
Immune	NULL
Pre	NULL
Immune	NULL
Pre	NULL
.	NULL

Immune	NULL
Pre	NULL
Immune	NULL
td	NULL
he	NULL
“	NULL
o	NULL
sn	NULL
oo	NULL
1d	NULL
ttn	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Jurkat	NULL
PEBP2	NULL
,	NULL
(	NULL
181	NULL
Fig	NULL
8	NULL
.	NULL

Reactivity	NULL
of	NULL
Jurkat	NULL
PEBP2	NULL
site-specific	NULL
protein-DNA	NULL
complex	NULL
to	NULL
anti-PEBP2	NULL
«	NULL
A1	NULL
serum	NULL
.	NULL

WCE	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
,	NULL
unstimulated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
TPA/PHA-stimulated	NULL
for	NULL
24	NULL
hours	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
or	NULL
WCE	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
from	NULL
P19	NULL
cells	NULL
transfected	NULL
with	NULL
PEBP2	NULL
«	NULL
eA1	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
or	NULL
«	NULL
B1	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
was	NULL
preincubated	NULL
with	NULL
preimmune	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
or	NULL
anti-PEBP2	NULL
«	NULL
A1	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
rabbit	NULL
serum	NULL
for	NULL
15	NULL
minutes	NULL
on	NULL
ice	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
using	NULL
end-labeled	NULL
wt	NULL
probe	NULL
and	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
PEBP-2	NULL
«	NULL
A1-	NULL
or	NULL
aB1-containing	NULL
complexes	NULL
and	NULL
Jurkat	NULL
PEBP2	NULL
site-specific	NULL
complex	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

tected	NULL
that	NULL
is	NULL
antigenically	NULL
related	NULL
to	NULL
mouse	NULL
aA1	NULL
and	NULL
aBI	NULL
proteins	NULL
.	NULL

The	NULL
present	NULL
study	NULL
indicated	NULL
that	NULL
PEBP2	NULL
@	NULL
B2	NULL
had	NULL
a	NULL
repressor-like	NULL
activity	NULL
when	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

This	NULL
seems	NULL
to	NULL
be	NULL
contradictory	NULL
to	NULL
our	NULL
previous	NULL
report	NULL
that	NULL
«	NULL
B2	NULL
is	NULL
a	NULL
transactivator	NULL
when	NULL
assayed	NULL
in	NULL
P19	NULL
cells	NULL
.	NULL
``	NULL

«	NULL
BI	NULL
is	NULL
the	NULL
full-size	NULL
«	NULL
B	NULL
isoform	NULL
with	NULL
a	NULL
maximum	NULL
transactivation	NULL
potential	NULL
.	NULL

«	NULL
B2	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
is	NULL
only	NULL
25	NULL
%	NULL
to	NULL
45	NULL
%	NULL
as	NULL
active	NULL
as	NULL
«	NULL
BI	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

Although	NULL
«	NULL
B2	NULL
functions	NULL
as	NULL
a	NULL
transactivator	NULL
when	NULL
tested	NULL
in	NULL
the	NULL
cells	NULL
where	NULL
there	NULL
is	NULL
no	NULL
endogenous	NULL
PEBP	NULL
?	NULL

activity	NULL
,	NULL
one	NULL
can	NULL
imagine	NULL
that	NULL
«	NULL
B2	NULL
could	NULL
inhibit	NULL
transcription	NULL
within	NULL
the	NULL
cells	NULL
where	NULL
the	NULL
average	NULL
endogenous	NULL
PEBP2	NULL
activity	NULL
is	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
«	NULL
B2	NULL
.	NULL

Several	NULL
examples	NULL
of	NULL
negative	NULL
regulation	NULL
by	NULL
a	NULL
weaker	NULL
transactivator	NULL
have	NULL
been	NULL
reported	NULL
.	NULL
``	NULL

Alternatively	NULL
,	NULL
the	NULL
repressor-like	NULL
function	NULL
of	NULL
«	NULL
B2	NULL
may	NULL
be	NULL
specific	NULL
for	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
the	NULL
TCR/	NULL
#	NULL
3	NULL
enhancer	NULL
linked	NULL
to	NULL
herpesvirus	NULL
thymidine	NULL
kinase	NULL
gene	NULL
promoter	NULL
,	NULL
``	NULL
``	NULL
the	NULL
potential	NULL
negative	NULL
reg-	NULL
613	NULL
ulatory	NULL
function	NULL
would	NULL
be	NULL
alleviated	NULL
by	NULL
interaction	NULL
of	NULL
«	NULL
B2	NULL
with	NULL
other	NULL
factors	NULL
bound	NULL
to	NULL
adjacent	NULL
sites	NULL
.	NULL

The	NULL
overall	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
was	NULL
increased	NULL
by	NULL
fivefold	NULL
by	NULL
the	NULL
TPA/PHA	NULL
stimulation	NULL
.	NULL

Transcription	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
elements	NULL
located	NULL
between	NULL
-91	NULL
to	NULL
-73	NULL
and	NULL
-54	NULL
to	NULL
-40	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
this	NULL
process	NULL
.	NULL

'*'*	NULL
'	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
What	NULL
could	NULL
be	NULL
the	NULL
role	NULL
of	NULL
PEBP2	NULL
?	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
PEBP2/CBF	NULL
and	NULL
another	NULL
transcription	NULL
factor	NULL
,	NULL
Ets-1	NULL
,	NULL
cooperatively	NULL
bind	NULL
to	NULL
DNA	NULL
.	NULL
``	NULL

We	NULL
have	NULL
evidence	NULL
that	NULL
PEBP2	NULL
hardly	NULL
stimulates	NULL
transcription	NULL
by	NULL
itself	NULL
but	NULL
it	NULL
functionally	NULL
cooperates	NULL
with	NULL
Ets-1	NULL
in	NULL
vivo	NULL
.	NULL

Therefore	NULL
,	NULL
PEBP2	NULL
appears	NULL
to	NULL
stimulate	NULL
transcription	NULL
by	NULL
stabilizing	NULL
the	NULL
binding	NULL
of	NULL
Ets-1	NULL
or	NULL
other	NULL
activator	NULL
proteins	NULL
to	NULL
DNA	NULL
(	NULL
E.	NULL
Ogawa	NULL
and	NULL
Y.	NULL
Ito	NULL
,	NULL
unpublished	NULL
observa-tion	NULL
)	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
that	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
before	NULL
the	NULL
TPA/PHA	NULL
stimulation	NULL
is	NULL
reduced	NULL
by	NULL
50	NULL
%	NULL
by	NULL
exogenous	NULL
expression	NULL
of	NULL
«	NULL
B2	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
not	NULL
observed	NULL
when	NULL
the	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
61.62	NULL
mutation	NULL
is	NULL
used	NULL
.	NULL

Therefore	NULL
,	NULL
«	NULL
B2	NULL
must	NULL
have	NULL
interfered	NULL
with	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
in	NULL
a	NULL
transdominant	NULL
negative	NULL
fashion	NULL
,	NULL
strongly	NULL
suggesting	NULL
that	NULL
the	NULL
endogenous	NULL
PEBP2	NULL
is	NULL
contributing	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
significantly	NULL
.	NULL

Although	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
reduction	NULL
was	NULL
only	NULL
50	NULL
%	NULL
,	NULL
it	NULL
was	NULL
not	NULL
surprizing	NULL
because	NULL
«	NULL
B2	NULL
is	NULL
25	NULL
%	NULL
to	NULL
45	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
full-size	NULL
protein	NULL
,	NULL
aB1	NULL
.	NULL

*	NULL
When	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
TPA/PHA	NULL
and	NULL
the	NULL
overall	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
increased	NULL
by	NULL
about	NULL
fivefold	NULL
,	NULL
exogenously	NULL
expressed	NULL
«	NULL
B2	NULL
also	NULL
showed	NULL
the	NULL
PEBP2	NULL
site-dependent	NULL
reduction	NULL
of	NULL
the	NULL
activity	NULL
.	NULL

Once	NULL
again	NULL
,	NULL
the	NULL
result	NULL
shows	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
endogenous	NULL
PEBP2	NULL
in	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
both	NULL
states	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
ie	NULL
,	NULL
before	NULL
and	NULL
after	NULL
the	NULL
TPA/PHA	NULL
stimulation	NULL
)	NULL
,	NULL
the	NULL
61.62	NULL
mutation	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

We	NULL
interpreted	NULL
the	NULL
result	NULL
to	NULL
mean	NULL
that	NULL
particular	NULL
ratios	NULL
of	NULL
the	NULL
«	NULL
A1	NULL
,	NULL
«	NULL
B1	NULL
,	NULL
and	NULL
«	NULL
B2	NULL
proteins	NULL
,	NULL
as	NULL
well	NULL
as	NULL
perhaps	NULL
as	NULL
yet	NULL
unknown	NULL
PEBP2	NULL
site-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
in	NULL
the	NULL
two	NULL
states	NULL
are	NULL
such	NULL
that	NULL
the	NULL
positive	NULL
and	NULL
negative	NULL
effects	NULL
on	NULL
the	NULL
PEBP2	NULL
site	NULL
are	NULL
balanced	NULL
at	NULL
the	NULL
levels	NULL
observed	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
the	NULL
mutation	NULL
61.62	NULL
would	NULL
not	NULL
affect	NULL
the	NULL
overall	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
see	NULL
the	NULL
effect	NULL
of	NULL
mu-tation	NULL
,	NULL
we	NULL
should	NULL
change	NULL
the	NULL
relative	NULL
ratio	NULL
of	NULL
the	NULL
individual	NULL
a	NULL
proteins	NULL
.	NULL

In	NULL
effect	NULL
,	NULL
this	NULL
is	NULL
precisely	NULL
what	NULL
we	NULL
are	NULL
observing	NULL
in	NULL
Fig	NULL
4	NULL
.	NULL

By	NULL
adding	NULL
«	NULL
B2	NULL
,	NULL
we	NULL
increased	NULL
the	NULL
negative	NULL
force	NULL
.	NULL

There	NULL
,	NULL
we	NULL
observed	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
mutation	NULL
.	NULL

Similarly	NULL
,	NULL
exogenous	NULL
expression	NULL
of	NULL
«	NULL
BI	NULL
shifted	NULL
the	NULL
balance	NULL
in	NULL
such	NULL
a	NULL
way	NULL
as	NULL
to	NULL
increase	NULL
the	NULL
positive	NULL
force	NULL
.	NULL

There	NULL
,	NULL
we	NULL
saw	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
mutation	NULL
.	NULL

In	NULL
mouse	NULL
T-cell	NULL
lines	NULL
,	NULL
PEBP2aB	NULL
!	NULL

and	NULL
«	NULL
B2	NULL
mRNAs	NULL
were	NULL
detected	NULL
by	NULL
RT-PCR	NULL
(	NULL
Bae	NULL
S-C	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
PEBP2aB	NULL
in	NULL
normal	NULL
murine	NULL
thymocytes	NULL
was	NULL
revealed	NULL
by	NULL
in	NULL
situ	NULL
hybridiza-tion	NULL
.	NULL
``	NULL

''	NULL
Nevertheless	NULL
,	NULL
further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
draw	NULL
any	NULL
conclusion	NULL
about	NULL
the	NULL
regulatory	NULL
role	NULL
of	NULL
PEBP2	NULL
in	NULL
the	NULL
GM-CSF	NULL
production	NULL
by	NULL
normal	NULL
T	NULL
cells	NULL
.	NULL

An	NULL
attractive	NULL
hypothesis	NULL
would	NULL
be	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
promoter	NULL
activities	NULL
of	NULL
target	NULL
genes	NULL
are	NULL
determined	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
distinct	NULL
patterns	NULL
of	NULL
PEBP2a	NULL
expression	NULL
.	NULL

Characteristic	NULL
modes	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
target	NULL
genes	NULL
may	NULL
be	NULL
maintained	NULL
by	NULL
cell-	NULL
or	NULL
tissue-specific	NULL
ratios	NULL
of	NULL
the	NULL
different	NULL
PEBP2a	NULL
isoforms	NULL
.	NULL

There	NULL
are	NULL
other	NULL
mRNA	NULL
species	NULL
of	NULL
PEB-P2a	NULL
«	NULL
B	NULL
that	NULL
may	NULL
encode	NULL
different	NULL
isoforms	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

614	NULL
human	NULL
AML1	NULL
PEBP20A	NULL
-	NULL
+	NULL
-	NULL
+	NULL
«	NULL
<	NULL
ftz~	NULL
-	NULL
‘	NULL
V	NULL
’	NULL
o	NULL
,	NULL
ﬂ	NULL
-	NULL
8.0	NULL
kb	NULL
--	NULL
6.5	NULL
kb	NULL
#	NULL
A	NULL
,	NULL
.	NULL

288	NULL
-	NULL
3.9	NULL
kb	NULL
5	NULL
gual	NULL
-	NULL
2.4	NULL
kb	NULL
m	NULL
___	NULL
-_	NULL
-I	NULL
18s	NULL
-_	NULL
1	NULL
2	NULL
3	NULL
4	NULL
clarified	NULL
whether	NULL
other	NULL
genes	NULL
exist	NULL
that	NULL
encode	NULL
PEBP2	NULL
site-binding	NULL
proteins	NULL
.	NULL

Cloning	NULL
of	NULL
all	NULL
cDNAs	NULL
of	NULL
the	NULL
PEBP2	NULL
family	NULL
,	NULL
characterization	NULL
of	NULL
proteins	NULL
encoded	NULL
by	NULL
them	NULL
,	NULL
assessment	NULL
of	NULL
their	NULL
effects	NULL
on	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
promoter	NULL
or	NULL
enhancer	NULL
of	NULL
target	NULL
genes	NULL
,	NULL
and	NULL
analysis	NULL
of	NULL
their	NULL
expression	NULL
in	NULL
various	NULL
cells	NULL
and	NULL
tissues	NULL
are	NULL
clearly	NULL
necessary	NULL
.	NULL

Our	NULL
present	NULL
findings	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
is	NULL
one	NULL
of	NULL
the	NULL
targets	NULL
of	NULL
the	NULL
PEBP2	NULL
.	NULL

A	NULL
single	NULL
bind-ing-site	NULL
within	NULL
the	NULL
upstream	NULL
element	NULL
seems	NULL
to	NULL
be	NULL
sufficient	NULL
for	NULL
its	NULL
transcriptional	NULL
regulatory	NULL
activity	NULL
.	NULL

By	NULL
computer-aided	NULL
sequence	NULL
search	NULL
,	NULL
we	NULL
further	NULL
noted	NULL
that	NULL
PEBP2	NULL
consensus	NULL
sequences	NULL
also	NULL
occur	NULL
within	NULL
the	NULL
promoters	NULL
of	NULL
various	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
interleukin-3	NULL
,	NULL
``	NULL
``	NULL
MIP1a/LD78	NULL
,	NULL
``	NULL
``	NULL
myeloperoxidase	NULL
,	NULL
``	NULL
and	NULL
the	NULL
human	NULL
eosinophil	NULL
Charcot-Leyden	NULL
crystal	NULL
protein	NULL
.	NULL
``	NULL

In	NULL
fact	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
PEBP2/CBF	NULL
sites	NULL
in	NULL
interleukin-3	NULL
and	NULL
myeloperoxidase	NULL
promoters	NULL
are	NULL
functionally	NULL
important	NULL
.	NULL

``	NULL
*	NULL
'	NULL
The	NULL
promoter	NULL
activity	NULL
could	NULL
be	NULL
regulated	NULL
by	NULL
positive	NULL
or	NULL
negative	NULL
regulators	NULL
generated	NULL
from	NULL
several	NULL
distinct	NULL
PEBP2a	NULL
genes	NULL
through	NULL
differential	NULL
posttranscriptional	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
posttranslational	NULL
modifications	NULL
.	NULL

Accumulating	NULL
evidence	NULL
suggests	NULL
that	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
are	NULL
controlled	NULL
by	NULL
ordered	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
transcription	NULL
factors	NULL
and	NULL
involve	NULL
a	NULL
controlled	NULL
balance	NULL
between	NULL
positively	NULL
and	NULL
negatively	NULL
acting	NULL
factors	NULL
.	NULL

A	NULL
subversion	NULL
of	NULL
this	NULL
controlled	NULL
equilibrium	NULL
``	NULL
may	NULL
underlie	NULL
the	NULL
leukemogenesis	NULL
by	NULL
chromosomal	NULL
translocations	NULL
creating	NULL
chi-meric	NULL
proteins	NULL
,	NULL
``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
*	NULL
``	NULL
*	NULL
which	NULL
may	NULL
have	NULL
unusual	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
.	NULL

Further	NULL
study	NULL
on	NULL
the	NULL
function	NULL
of	NULL
each	NULL
PEBP2	NULL
«	NULL
protein	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
each	NULL
target	NULL
gene	NULL
would	NULL
show	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
PEBP2	NULL
transcription	NULL
factors	NULL
in	NULL
physiology	NULL
and	NULL
pathophysiology	NULL
,	NULL
such	NULL
as	NULL
embryonic	NULL
devel-opment	NULL
,	NULL
``	NULL
T-cell	NULL
differentiation	NULL
,	NULL
``	NULL
and	NULL
leukemogenesis	NULL
.	NULL
``	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Dr	NULL
M.	NULL
Ohki	NULL
(	NULL
National	NULL
Cancer	NULL
Center	NULL
Institute	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
AML	NULL
1	NULL
probe	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Y.	NULL
Murakami	NULL
,	NULL
E.	NULL
Ogawa	NULL
,	NULL
H.	NULL
TAKAHASHI	NULL
ET	NULL
AL	NULL
human	NULL
PEBP2B	NULL
Fig	NULL
9	NULL
.	NULL

Expression	NULL
of	NULL
human	NULL
PEBP2	NULL
mRNAs	NULL
.	NULL

Northern	NULL
blots	NULL
were	NULL
prepared	NULL
using	NULL
2	NULL
ug	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
5	NULL
ug	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
isolated	NULL
from	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
TPA/PHA-stimulated	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Each	NULL
blot	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
human	NULL
-	NULL
AML1/PEBP2eB	NULL
-	NULL
probe	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
a	NULL
human	NULL
PEB-P2	NULL
«	NULL
A	NULL
probe	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
or	NULL
a	NULL
human	NULL
probe	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Lower	NULL
panels	NULL
show	NULL
the	NULL
areas	NULL
of	NULL
the	NULL
same	NULL
blots	NULL
as	NULL
above	NULL
n	NULL
B-actin	NULL
__	NULL
rehybridized	NULL
with	NULL
a	NULL
human	NULL
B-actin	NULL
probe	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
28S	NULL
and	NULL
18S	NULL
rRNAs	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Major	NULL
species	NULL
of	NULL
mRNAs	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
5	NULL
6	NULL
with	NULL
their	NULL
approximate	NULL
sizes	NULL
.	NULL

n	NULL
-3.6	NULL
kb	NULL
Ishikawa	NULL
,	NULL
C.	NULL
Sakakura	NULL
,	NULL
and	NULL
T.	NULL
Kanda	NULL
(	NULL
from	NULL
the	NULL
Institute	NULL
for	NULL
Virus	NULL
Research	NULL
,	NULL
Kyoto	NULL
University	NULL
,	NULL
Kyoto	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
suggestions	NULL
;	NULL
M.	NULL
Kumamoto	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
and	NULL
Y.	NULL
Fujita	NULL
for	NULL
secretarial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Gasson	NULL
JC	NULL
:	NULL
Molecular	NULL
physiology	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Blood	NULL
77:1131	NULL
,	NULL
1991	NULL
2	NULL
.	NULL

Metcalf	NULL
D	NULL
:	NULL
The	NULL
molecular	NULL
control	NULL
of	NULL
cell	NULL
division	NULL
,	NULL
differentiation	NULL
commitment	NULL
and	NULL
maturation	NULL
in	NULL
haematopoietic	NULL
cells	NULL
.	NULL

Nature	NULL
339:27	NULL
,	NULL
1989	NULL
3	NULL
.	NULL

Pech	NULL
N	NULL
,	NULL
Hermine	NULL
O	NULL
,	NULL
Goldwasser	NULL
E	NULL
:	NULL
Further	NULL
study	NULL
of	NULL
internal	NULL
autocrine	NULL
regulation	NULL
of	NULL
multipotent	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
82:1502	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Lopez	NULL
AF	NULL
,	NULL
Williamson	NULL
DJ	NULL
,	NULL
Gamble	NULL
JR	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Harlan	NULL
JM	NULL
,	NULL
Klebanoff	NULL
SJ	NULL
,	NULL
Waltersdorph	NULL
A	NULL
,	NULL
Wong	NULL
G	NULL
,	NULL
Clark	NULL
SC	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
Recombinant	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
stimulates	NULL
in	NULL
vitro	NULL
mature	NULL
human	NULL
neutrophil	NULL
and	NULL
eosinophil	NULL
function	NULL
,	NULL
surface	NULL
receptor	NULL
expression	NULL
,	NULL
and	NULL
survival	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
78:1220	NULL
,	NULL
1986	NULL
5	NULL
.	NULL

Xu	NULL
WD	NULL
,	NULL
Firestein	NULL
GS	NULL
,	NULL
Taetle	NULL
R	NULL
,	NULL
Kaushansky	NULL
K	NULL
,	NULL
Zvaiflier	NULL
NJ	NULL
:	NULL
Cytokines	NULL
in	NULL
chronic	NULL
inflammatory	NULL
arthritis	NULL
.	NULL

II	NULL
.	NULL

Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
in	NULL
rheumatoid	NULL
synovial	NULL
effusions	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
83:876	NULL
,	NULL
1989	NULL
6	NULL
.	NULL

Young	NULL
DC	NULL
,	NULL
Griffin	NULL
JD	NULL
:	NULL
Autocrine	NULL
secretion	NULL
of	NULL
GM-CSF	NULL
in	NULL
acute	NULL
myeloblastic	NULL
leukemia	NULL
.	NULL

Blood	NULL
68:1178,1986	NULL
7	NULL
.	NULL

Gough	NULL
NM	NULL
:	NULL
Leukemogenic	NULL
potential	NULL
of	NULL
the	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
GM-CSF	NULL
and	NULL
its	NULL
receptor	NULL
,	NULL
in	NULL
Brugge	NULL
J	NULL
,	NULL
Curran	NULL
T	NULL
,	NULL
Harlow	NULL
E	NULL
,	NULL
McCormick	NULL
F	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Origins	NULL
of	NULL
Human	NULL
Cancer	NULL
:	NULL
A	NULL
Comprehensive	NULL
Review	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1991	NULL
,	NULL
p	NULL
485	NULL
8	NULL
.	NULL

Areces	NULL
LB	NULL
,	NULL
Jiicker	NULL
M	NULL
,	NULL
San	NULL
Miguel	NULL
JA	NULL
,	NULL
Mui	NULL
A	NULL
,	NULL
Miyajima	NULL
A	NULL
,	NULL
Feldman	NULL
RA	NULL
:	NULL
Ligand-dependent	NULL
transformation	NULL
by	NULL
the	NULL
receptor	NULL
for	NULL
human	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
tyro-sine	NULL
phosphorylation	NULL
of	NULL
the	NULL
receptor	NULL
/3	NULL
subunit	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:3963	NULL
,	NULL
1993	NULL
9	NULL
.	NULL

Chan	NULL
JY	NULL
,	NULL
Slamon	NULL
DJ	NULL
,	NULL
Nimer	NULL
SD	NULL
,	NULL
Golde	NULL
DW	NULL
,	NULL
Gasson	NULL
JC	NULL
:	NULL
Regulation	NULL
of	NULL
expression	NULL
of	NULL
human	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:8669	NULL
,	NULL
1986	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

REGULATION	NULL
OF	NULL
GM-CSF	NULL
PROMOTER	NULL
BY	NULL
PEBP2	NULL
10	NULL
.	NULL

Nimer	NULL
SD	NULL
,	NULL
Morita	NULL
EA	NULL
,	NULL
Martis	NULL
MJ	NULL
,	NULL
Wachsman	NULL
W	NULL
,	NULL
Gasson	NULL
JC	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
region	NULL
by	NULL
genetic	NULL
analysis	NULL
:	NULL
Correlation	NULL
with	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:1979	NULL
,	NULL
1988	NULL
11	NULL
.	NULL

Miyatake	NULL
S	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Yoshida	NULL
M	NULL
,	NULL
Arai	NULL
K-I	NULL
:	NULL
T-cell	NULL
activation	NULL
signals	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-encoded	NULL
p40	NULL
``	NULL
protein	NULL
activate	NULL
the	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
through	NULL
a	NULL
common	NULL
DNA	NULL
element	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:5581	NULL
,	NULL
1988	NULL
12	NULL
.	NULL

Sugimoto	NULL
K	NULL
,	NULL
Tsuboi	NULL
A	NULL
,	NULL
Miyatake	NULL
S	NULL
,	NULL
Arai	NULL
K	NULL
,	NULL
Arai	NULL
N	NULL
:	NULL
Inducible	NULL
and	NULL
non-inducible	NULL
factors	NULL
co-operatively	NULL
activate	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
by	NULL
interacting	NULL
with	NULL
two	NULL
adjacent	NULL
DNA	NULL
motifs	NULL
.	NULL

Int	NULL
Immunol	NULL
2:787	NULL
,	NULL
1990	NULL
13	NULL
.	NULL

Nimer	NULL
SD	NULL
,	NULL
Fraser	NULL
J	NULL
,	NULL
Richards	NULL
J	NULL
,	NULL
Lynch	NULL
M	NULL
,	NULL
Gasson	NULL
J	NULL
:	NULL
The	NULL
repeated	NULL
sequence	NULL
CATT	NULL
(	NULL
A/T	NULL
)	NULL
is	NULL
required	NULL
for	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
activity	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:6084	NULL
,	NULL
1990	NULL
14	NULL
.	NULL

Miyatake	NULL
S	NULL
,	NULL
Shlomai	NULL
J	NULL
,	NULL
Arai	NULL
K-I	NULL
,	NULL
Arai	NULL
N	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
promoter	NULL
:	NULL
Nuclear	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
an	NULL
element	NULL
shared	NULL
by	NULL
three	NULL
lymphokine	NULL
genes	NULL
-	NULL
Those	NULL
for	NULL
GM-CSF	NULL
,	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
,	NULL
and	NULL
IL-5	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:5894	NULL
,	NULL
1991	NULL
15	NULL
.	NULL

Masuda	NULL
ES	NULL
,	NULL
Tokumitsu	NULL
H	NULL
,	NULL
Tsuboi	NULL
A	NULL
,	NULL
Shlomai	NULL
J	NULL
,	NULL
Hung	NULL
P	NULL
,	NULL
Arai	NULL
K-I	NULL
,	NULL
Arai	NULL
N	NULL
:	NULL
The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
cis-acting	NULL
element	NULL
CLEO	NULL
mediates	NULL
induction	NULL
signals	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
recognized	NULL
by	NULL
factors	NULL
related	NULL
to	NULL
API	NULL
and	NULL
NFAT	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:7399	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Cockerill	NULL
PN	NULL
,	NULL
Shannon	NULL
MF	NULL
,	NULL
Bert	NULL
AG	NULL
,	NULL
Ryan	NULL
GR	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor/interleukin	NULL
3	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
cyclosporin	NULL
A-sensitive	NULL
enhancer	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:2466	NULL
,	NULL
1993	NULL
17	NULL
.	NULL

Shaw	NULL
G	NULL
,	NULL
Kamen	NULL
R	NULL
:	NULL
A	NULL
conserved	NULL
AU	NULL
sequence	NULL
from	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
mediates	NULL
selective	NULL
mRNA	NULL
degradation	NULL
.	NULL

Cell	NULL
46:659	NULL
,	NULL
1986	NULL
18	NULL
.	NULL

Schuller	NULL
GD	NULL
,	NULL
Cole	NULL
MD	NULL
:	NULL
GM-CSF	NULL
and	NULL
oncogene	NULL
mRNA	NULL
sta-bilities	NULL
are	NULL
independently	NULL
regulated	NULL
in	NULL
trans	NULL
in	NULL
a	NULL
mouse	NULL
monocytic	NULL
tumor	NULL
.	NULL

Cell	NULL
55:1115	NULL
,	NULL
1988	NULL
19	NULL
.	NULL

Lindstein	NULL
T	NULL
,	NULL
June	NULL
CH	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Stella	NULL
G	NULL
,	NULL
Thompson	NULL
CB	NULL
:	NULL
Regulation	NULL
of	NULL
lymphokine	NULL
messenger	NULL
RNA	NULL
stability	NULL
by	NULL
a	NULL
surface-mediated	NULL
T	NULL
cell	NULL
activation	NULL
pathway	NULL
.	NULL

Science	NULL
244:339	NULL
,	NULL
1989	NULL
20	NULL
.	NULL

Shannon	NULL
MF	NULL
,	NULL
Gamble	NULL
JR	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
Nuclear	NULL
proteins	NULL
interacting	NULL
with	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:674	NULL
,	NULL
1988	NULL
21	NULL
.	NULL

Schreck	NULL
R	NULL
,	NULL
Bacuerle	NULL
PA	NULL
:	NULL
NF-k	NULL
B	NULL
as	NULL
inducible	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:1281	NULL
,	NULL
1990	NULL
22	NULL
.	NULL

Tsuboi	NULL
A	NULL
,	NULL
Sugimoto	NULL
K	NULL
,	NULL
Yodoi	NULL
J	NULL
,	NULL
Miyatake	NULL
S	NULL
,	NULL
Arai	NULL
K-I	NULL
,	NULL
Arai	NULL
N	NULL
:	NULL
A	NULL
nuclear	NULL
factor	NULL
NF-GM2	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
essential	NULL
for	NULL
its	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
:	NULL
Purification	NULL
from	NULL
human	NULL
T-cell	NULL
leukemia	NULL
line	NULL
Jurkat	NULL
cells	NULL
and	NULL
similarity	NULL
to	NULL
NF-k	NULL
B.	NULL
Int	NULL
Immunol	NULL
3:807	NULL
,	NULL
1991	NULL
23	NULL
.	NULL

Wang	NULL
C-Y	NULL
,	NULL
Bassuk	NULL
AG	NULL
,	NULL
Boise	NULL
LH	NULL
,	NULL
Thompson	NULL
CB	NULL
,	NULL
Bravo	NULL
R	NULL
,	NULL
Leiden	NULL
JM	NULL
:	NULL
Activation	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
requires	NULL
cooperative	NULL
binding	NULL
of	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:1153	NULL
,	NULL
1994	NULL
24	NULL
.	NULL

Kamachi	NULL
Y	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
Asano	NULL
M	NULL
,	NULL
Ishida	NULL
S	NULL
,	NULL
Murakami	NULL
Y	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Ito	NULL
Y	NULL
,	NULL
Shigesada	NULL
K	NULL
:	NULL
Purification	NULL
of	NULL
a	NULL
mouse	NULL
nuclear	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
both	NULL
the	NULL
A	NULL
and	NULL
B	NULL
cores	NULL
of	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
.	NULL

J	NULL
Virol	NULL
64:4808	NULL
,	NULL
1990	NULL
25	NULL
.	NULL

Satake	NULL
M	NULL
,	NULL
Ibaraki	NULL
T	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Modulation	NULL
of	NULL
polyomavirus	NULL
enhancer	NULL
binding	NULL
proteins	NULL
by	NULL
Ha-ras	NULL
oncogene	NULL
.	NULL

Oncogene	NULL
3:69	NULL
,	NULL
1988	NULL
26	NULL
.	NULL

Satake	NULL
M	NULL
,	NULL
Inuzuka	NULL
M	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Oikawa	NULL
T	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
subspecies	NULL
of	NULL
polyomavirus	NULL
and	NULL
murine	NULL
leuke-	NULL
615	NULL
mia	NULL
virus	NULL
enhancer	NULL
core	NULL
binding	NULL
protein	NULL
,	NULL
PEBP2	NULL
,	NULL
in	NULL
various	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Jpn	NULL
J	NULL
Cancer	NULL
Res	NULL
83:714	NULL
,	NULL
1992	NULL
27	NULL
.	NULL

Wang	NULL
S	NULL
,	NULL
Wang	NULL
Q	NULL
,	NULL
Crute	NULL
BE	NULL
,	NULL
Melnikova	NULL
IN	NULL
,	NULL
Keller	NULL
SR	NULL
,	NULL
Speck	NULL
NA	NULL
:	NULL
Cloning	NULL
and	NULL
characterization	NULL
of	NULL
subunits	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
core-binding	NULL
factor	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:3324	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Piette	NULL
J	NULL
,	NULL
Yaniv	NULL
M	NULL
:	NULL
Two	NULL
different	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
e-domain	NULL
of	NULL
the	NULL
polyoma	NULL
virus	NULL
enhancer	NULL
,	NULL
one	NULL
of	NULL
which	NULL
also	NULL
interacts	NULL
with	NULL
the	NULL
SV40	NULL
and	NULL
c-fos	NULL
enhancers	NULL
.	NULL

EMBO	NULL
J	NULL
6:1331	NULL
,	NULL
1987	NULL
29	NULL
.	NULL

Murakami	NULL
Y	NULL
,	NULL
Asano	NULL
M	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
A	NULL
tumor	NULL
promoting	NULL
phorbol	NULL
ester	NULL
,	NULL
TPA	NULL
,	NULL
enhances	NULL
polyomavirus	NULL
DNA	NULL
replication	NULL
by	NULL
activating	NULL
the	NULL
function	NULL
of	NULL
the	NULL
viral	NULL
enhancer	NULL
.	NULL

Oncogene	NULL
5:5	NULL
,	NULL
1990	NULL
30	NULL
.	NULL

Ogawa	NULL
E	NULL
,	NULL
Inuzuka	NULL
M	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Naito-Fuji-moto	NULL
M	NULL
,	NULL
Ito	NULL
Y	NULL
,	NULL
Shigesada	NULL
K	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
PEBP2	NULL
,	NULL
/3	NULL
,	NULL
the	NULL
heterodimeric	NULL
partner	NULL
of	NULL
a	NULL
novel	NULL
Drosophila	NULL
runt-related	NULL
DNA	NULL
binding	NULL
protein	NULL
PEBP2	NULL
«	NULL
.	NULL

Virology	NULL
194:314	NULL
,	NULL
1993	NULL
31	NULL
.	NULL

Ogawa	NULL
E	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Kagoshima	NULL
H	NULL
,	NULL
Inuzuka	NULL
M	NULL
,	NULL
Lu	NULL
J	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
PEBP2/PEA2	NULL
represents	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
homologous	NULL
to	NULL
the	NULL
products	NULL
of	NULL
the	NULL
Drosophila	NULL
runt	NULL
gene	NULL
and	NULL
the	NULL
human	NULL
AMLI	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:6859	NULL
,	NULL
1993	NULL
32	NULL
.	NULL

Bae	NULL
SC	NULL
,	NULL
Yamaguchi-Iwai	NULL
Y	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Inuzuka	NULL
M	NULL
,	NULL
Kagoshima	NULL
H	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Isolation	NULL
of	NULL
PEBP2aB	NULL
cDNA	NULL
representing	NULL
the	NULL
mouse	NULL
homolog	NULL
of	NULL
human	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
gene	NULL
,	NULL
AMLI	NULL
.	NULL

Oncogene	NULL
8:809	NULL
,	NULL
1993	NULL
33	NULL
.	NULL

Kania	NULL
MA	NULL
,	NULL
Bonner	NULL
AS	NULL
,	NULL
Duffy	NULL
JB	NULL
,	NULL
Gergen	NULL
JP	NULL
:	NULL
The	NULL
Drosophila	NULL
segmentation	NULL
gene	NULL
runt	NULL
encodes	NULL
a	NULL
novel	NULL
nuclear	NULL
regulatory	NULL
protein	NULL
that	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
the	NULL
developing	NULL
nervous	NULL
system	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1701	NULL
,	NULL
1990	NULL
34	NULL
.	NULL

Kagoshima	NULL
H	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Ito	NULL
Y	NULL
,	NULL
Miyoshi	NULL
H	NULL
,	NULL
Ohki	NULL
M	NULL
,	NULL
Pepling	NULL
M	NULL
,	NULL
Gergen	NULL
P	NULL
:	NULL
The	NULL
Runt	NULL
domain	NULL
identifies	NULL
a	NULL
new	NULL
family	NULL
of	NULL
heteromeric	NULL
transcriptional	NULL
regulators	NULL
.	NULL

Trends	NULL
Genet	NULL
9:338	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Bae	NULL
SC	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Oka	NULL
H	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Jenkins	NULL
NA	NULL
,	NULL
Gilbert	NULL
DJ	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
PEBP2	NULL
«	NULL
B/	NULL
mouse	NULL
AML	NULL
1	NULL
consists	NULL
of	NULL
multiple	NULL
isoforms	NULL
that	NULL
possess	NULL
differential	NULL
transactivation	NULL
potentials	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:3242	NULL
,	NULL
1994	NULL
36	NULL
.	NULL

Miyoshi	NULL
H	NULL
,	NULL
Shimizu	NULL
K	NULL
,	NULL
Kozu	NULL
T	NULL
,	NULL
Maseki	NULL
N	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Ohki	NULL
M	NULL
:	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
breakpoints	NULL
on	NULL
chromosome	NULL
21	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
are	NULL
clustered	NULL
within	NULL
a	NULL
limited	NULL
region	NULL
of	NULL
a	NULL
single	NULL
gene	NULL
,	NULL
AML	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:10431	NULL
,	NULL
1991	NULL
37	NULL
.	NULL

Nucifora	NULL
G	NULL
,	NULL
Birn	NULL
DJ	NULL
,	NULL
Espinosa	NULL
R	NULL
,	NULL
Erickson	NULL
P	NULL
,	NULL
LeBeau	NULL
MM	NULL
,	NULL
Roulston	NULL
D	NULL
,	NULL
McKeithan	NULL
TW	NULL
,	NULL
Drabkin	NULL
H	NULL
,	NULL
Rowley	NULL
JD	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
AML1	NULL
gene	NULL
in	NULL
the	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
in	NULL
therapy-related	NULL
leukemia	NULL
and	NULL
in	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
in	NULL
blast	NULL
crisis	NULL
.	NULL

Blood	NULL
81:2728	NULL
,	NULL
1993	NULL
38	NULL
.	NULL

Mitani	NULL
K	NULL
,	NULL
Ogawa	NULL
S	NULL
,	NULL
Tanaka	NULL
T	NULL
,	NULL
Miyoshi	NULL
H	NULL
,	NULL
Kurokawa	NULL
M	NULL
,	NULL
Mano	NULL
H	NULL
,	NULL
Yazaki	NULL
Y	NULL
,	NULL
Ohki	NULL
M	NULL
,	NULL
and	NULL
Hirai	NULL
H	NULL
:	NULL
Generation	NULL
of	NULL
the	NULL
AML-1-EVI-1	NULL
fusion	NULL
gene	NULL
in	NULL
the	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
q22	NULL
)	NULL
causes	NULL
blastic	NULL
crisis	NULL
in	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
.	NULL

EMBO	NULL
J	NULL
13:504	NULL
,	NULL
1994	NULL
39	NULL
.	NULL

Liu	NULL
P	NULL
,	NULL
Tarlé	NULL
SA	NULL
,	NULL
Hajra	NULL
A	NULL
,	NULL
Claxton	NULL
DF	NULL
,	NULL
Marlton	NULL
P	NULL
,	NULL
Freedman	NULL
M	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Collins	NULL
FS	NULL
:	NULL
Fusion	NULL
between	NULL
transcription	NULL
factor	NULL
CBFP/PEBP2§	NULL
and	NULL
a	NULL
myosin	NULL
heavy	NULL
chain	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Science	NULL
261:1041	NULL
,	NULL
1993	NULL
40	NULL
.	NULL

Speck	NULL
NA	NULL
,	NULL
Renjifo	NULL
B	NULL
,	NULL
Golemis	NULL
E	NULL
,	NULL
Fredrickson	NULL
TN	NULL
,	NULL
Hartley	NULL
JW	NULL
,	NULL
Hopkins	NULL
N	NULL
:	NULL
Mutation	NULL
of	NULL
the	NULL
core	NULL
or	NULL
adjacent	NULL
LVb	NULL
elements	NULL
of	NULL
the	NULL
Molony	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
alters	NULL
disease	NULL
specific-ity	NULL
.	NULL

Genes	NULL
Dev	NULL
4:233	NULL
,	NULL
1990	NULL
41	NULL
.	NULL

Thornell	NULL
A	NULL
,	NULL
Hallberg	NULL
B	NULL
,	NULL
Grundstom	NULL
T	NULL
:	NULL
Binding	NULL
of	NULL
SL3-3	NULL
enhancer	NULL
factor	NULL
1	NULL
transcriptional	NULL
activators	NULL
to	NULL
viral	NULL
and	NULL
chromosomal	NULL
enhancer	NULL
sequences	NULL
.	NULL

J	NULL
Virol	NULL
65:42	NULL
,	NULL
1991	NULL
42	NULL
.	NULL

Redondo	NULL
JM	NULL
,	NULL
Pfohl	NULL
JL	NULL
,	NULL
Hernandez-Munain	NULL
C	NULL
,	NULL
Wang	NULL
S	NULL
,	NULL
Speck	NULL
NA	NULL
,	NULL
Krangel	NULL
MS	NULL
:	NULL
Indistinguishable	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
functional	NULL
core	NULL
sites	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
d	NULL
and	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancers	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:4817	NULL
,	NULL
1992	NULL
43	NULL
.	NULL

Satake	NULL
M	NULL
,	NULL
Nomura	NULL
S	NULL
,	NULL
Yamaguchi-Iwai	NULL
Y	NULL
,	NULL
Takahama	NULL
Y	NULL
,	NULL
Ha	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

616	NULL
shimoto	NULL
Y	NULL
,	NULL
Niki	NULL
M	NULL
,	NULL
Kitamura	NULL
Y	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
Runt	NULL
domain-encoding	NULL
PEBPZagenes	NULL
in	NULL
T	NULL
cells	NULL
during	NULL
thymic	NULL
development	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:1662	NULL
,	NULL
1995	NULL
44	NULL
.	NULL

Mizushima	NULL
S	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
pEF-BOS	NULL
,	NULL
a	NULL
powerful	NULL
mammalian	NULL
expression	NULL
vector	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
18:5322	NULL
,	NULL
1990	NULL
45	NULL
.	NULL

Inuzuka	NULL
M	NULL
,	NULL
Ishikawa	NULL
H	NULL
,	NULL
Kumar	NULL
S	NULL
,	NULL
Gelinas	NULL
C	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
The	NULL
viral	NULL
and	NULL
cellular	NULL
Rel	NULL
oncoproteins	NULL
induce	NULL
the	NULL
differentiation	NULL
of	NULL
P19	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

Oncogene	NULL
9:133	NULL
,	NULL
1994	NULL
46	NULL
.	NULL

Chen	NULL
C	NULL
,	NULL
Okayama	NULL
H	NULL
:	NULL
High-efficiency	NULL
transformation	NULL
of	NULL
mammalian	NULL
cells	NULL
by	NULL
plasmid	NULL
DNA	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
7:2745	NULL
,	NULL
1987	NULL
47	NULL
.	NULL

Taniguchi	NULL
T	NULL
,	NULL
Matsui	NULL
H	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Takaoka	NULL
C	NULL
,	NULL
Kashima	NULL
N	NULL
,	NULL
Yoshimoto	NULL
R	NULL
,	NULL
Hamuro	NULL
J	NULL
:	NULL
Structure	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
cloned	NULL
cDNA	NULL
for	NULL
human	NULL
interleukin-2	NULL
.	NULL

Nature	NULL
302:305	NULL
,	NULL
1983	NULL
48	NULL
.	NULL

Pagano	NULL
M	NULL
,	NULL
Diirst	NULL
M	NULL
,	NULL
Joswig	NULL
S	NULL
,	NULL
Draetta	NULL
G	NULL
,	NULL
Jansen-Diirr	NULL
P	NULL
:	NULL
Binding	NULL
of	NULL
the	NULL
human	NULL
E2F	NULL
transcription	NULL
factor	NULL
to	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
but	NULL
not	NULL
to	NULL
cyclin	NULL
A	NULL
is	NULL
abolished	NULL
in	NULL
HPV-16-immortalized	NULL
cells	NULL
.	NULL

Oncogene	NULL
7:1681	NULL
,	NULL
1992	NULL
49	NULL
.	NULL

Chodosh	NULL
LA	NULL
:	NULL
Mobility	NULL
shift	NULL
DNA-binding	NULL
assay	NULL
using	NULL
gel	NULL
electrophoresis	NULL
,	NULL
in	NULL
Ausubel	NULL
FM	NULL
,	NULL
Brent	NULL
R	NULL
,	NULL
Kingston	NULL
RE	NULL
,	NULL
Moore	NULL
DD	NULL
,	NULL
Seidman	NULL
JG	NULL
,	NULL
Smith	NULL
JA	NULL
,	NULL
Struhl	NULL
K	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Wiley	NULL
,	NULL
1988	NULL
,	NULL
p	NULL
12.2.1	NULL
50	NULL
.	NULL

Lu	NULL
J	NULL
,	NULL
Maruyama	NULL
M	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Bae	NULL
S-C	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
Kagoshima	NULL
H	NULL
,	NULL
Shigesada	NULL
K	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Subcellular	NULL
localization	NULL
of	NULL
the	NULL
a	NULL
and	NULL
#	NULL
subunits	NULL
of	NULL
the	NULL
acute	NULL
myeloid	NULL
leukemia-linked	NULL
transcription	NULL
factor	NULL
PEBP2/CBF	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:1651	NULL
,	NULL
1995	NULL
51	NULL
.	NULL

Razanajaona	NULL
D	NULL
,	NULL
Maroc	NULL
C	NULL
,	NULL
Lopez	NULL
M	NULL
,	NULL
Mannoni	NULL
P	NULL
,	NULL
Gabert	NULL
J	NULL
:	NULL
Shift	NULL
from	NULL
posttranscriptional	NULL
to	NULL
predominant	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
during	NULL
activation	NULL
of	NULL
human	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
3:299	NULL
,	NULL
1992	NULL
52	NULL
.	NULL

Takai	NULL
T	NULL
,	NULL
Ohmori	NULL
H	NULL
:	NULL
DNA	NULL
transfection	NULL
of	NULL
mouse	NULL
lymphoid	NULL
cells	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
DEAE-dextran-mediated	NULL
DNA	NULL
uptake	NULL
and	NULL
osmotic	NULL
shock	NULL
procedure	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1048:105	NULL
,	NULL
1990	NULL
53	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
ed	NULL
2	NULL
)	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1989	NULL
,	NULL
p	NULL
16	NULL
54	NULL
.	NULL

Edlund	NULL
T	NULL
,	NULL
Walker	NULL
MD	NULL
,	NULL
Barr	NULL
PJ	NULL
,	NULL
Rutter	NULL
WJ	NULL
:	NULL
Cell-specific	NULL
expression	NULL
of	NULL
the	NULL
rat	NULL
insulin	NULL
gene	NULL
:	NULL
Evidence	NULL
for	NULL
role	NULL
of	NULL
two	NULL
distinct	NULL
5	NULL
'	NULL
flanking	NULL
elements	NULL
.	NULL

Science	NULL
230:912	NULL
,	NULL
1985	NULL
55	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
56	NULL
.	NULL

Church	NULL
GM	NULL
,	NULL
Gilbert	NULL
W	NULL
:	NULL
Genomic	NULL
sequencing	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
81:1991	NULL
,	NULL
1984	NULL
57	NULL
.	NULL

Foulkes	NULL
NS	NULL
,	NULL
Sassone-Corsi	NULL
P	NULL
:	NULL
More	NULL
is	NULL
better	NULL
:	NULL
Activators	NULL
and	NULL
repressors	NULL
from	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

Cell	NULL
68:411	NULL
,	NULL
1992	NULL
58	NULL
.	NULL

Wotton	NULL
D	NULL
,	NULL
Ghysdeal	NULL
J	NULL
,	NULL
Wang	NULL
S	NULL
,	NULL
Speck	NULL
NA	NULL
,	NULL
Owen	NULL
MJ	NULL
:	NULL
Cooperative	NULL
binding	NULL
of	NULL
Ets-1	NULL
and	NULL
core	NULL
binding	NULL
factor	NULL
to	NULL
DNA	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:840	NULL
,	NULL
1994	NULL
59	NULL
.	NULL

Cameron	NULL
S	NULL
,	NULL
Taylor	NULL
DS	NULL
,	NULL
Tepas	NULL
EC	NULL
,	NULL
Speck	NULL
NA	NULL
,	NULL
Prevot-Mathey	NULL
B	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
critical	NULL
regulatory	NULL
site	NULL
in	NULL
the	NULL
human	NULL
interleukin-3	NULL
promoter	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
.	NULL

Blood	NULL
83:2851	NULL
,	NULL
1994	NULL
TAKAHASHI	NULL
ET	NULL
AL	NULL
60	NULL
.	NULL

Nomiyama	NULL
H	NULL
,	NULL
Hieshima	NULL
K	NULL
,	NULL
Hirokawa	NULL
K	NULL
,	NULL
Hattori	NULL
T	NULL
,	NULL
Takatsuki	NULL
K	NULL
,	NULL
Miura	NULL
R	NULL
:	NULL
Characterization	NULL
of	NULL
cytokine	NULL
LD78	NULL
gene	NULL
promoters	NULL
:	NULL
Positive	NULL
and	NULL
negative	NULL
transcriptional	NULL
factors	NULL
bind	NULL
to	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
common	NULL
to	NULL
LD78	NULL
,	NULL
interleukin-3	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
promoters	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:2787	NULL
,	NULL
1993	NULL
61	NULL
.	NULL

Suzow	NULL
J	NULL
,	NULL
Friedman	NULL
AD	NULL
:	NULL
The	NULL
murine	NULL
myeloperoxidase	NULL
promoter	NULL
contains	NULL
several	NULL
functional	NULL
elements	NULL
,	NULL
one	NULL
of	NULL
which	NULL
binds	NULL
a	NULL
cell	NULL
type-restricted	NULL
transcriptional	NULL
factor	NULL
,	NULL
myeloid	NULL
nuclear	NULL
factor	NULL
1	NULL
(	NULL
MyNF1	NULL
)	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:2141	NULL
,	NULL
1993	NULL
62	NULL
.	NULL

Gomolin	NULL
HI	NULL
,	NULL
Yamaguchi	NULL
Y	NULL
,	NULL
Paulpillai	NULL
AV	NULL
,	NULL
Dvorak	NULL
LA	NULL
,	NULL
Ack-erman	NULL
SJ	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Human	NULL
eosinophil	NULL
Charcot-Leyden	NULL
crystal	NULL
protein	NULL
:	NULL
Cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
lysophospholipase	NULL
gene	NULL
promoter	NULL
.	NULL

Blood	NULL
82:1868	NULL
,	NULL
1993	NULL
63	NULL
.	NULL

Hunger	NULL
SP	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
Chimaeric	NULL
oncoproteins	NULL
resulting	NULL
from	NULL
chromosomal	NULL
translocations	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukaemia	NULL
.	NULL

Semin	NULL
Cancer	NULL
Biol	NULL
4:387	NULL
,	NULL
1993	NULL
64	NULL
.	NULL

Erickson	NULL
P	NULL
,	NULL
Gao	NULL
J	NULL
,	NULL
Chang	NULL
K-S	NULL
,	NULL
Look	NULL
T	NULL
,	NULL
Whisenant	NULL
E	NULL
,	NULL
Rai-mondi	NULL
S	NULL
,	NULL
Lasher	NULL
R	NULL
,	NULL
Trujillo	NULL
J	NULL
,	NULL
Rowley	NULL
J	NULL
,	NULL
Drabkin	NULL
H	NULL
:	NULL
Identification	NULL
of	NULL
breakpoints	NULL
in	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
and	NULL
isolation	NULL
of	NULL
a	NULL
fusion	NULL
transcript	NULL
,	NULL
AMLI/ETO	NULL
,	NULL
with	NULL
similarity	NULL
to	NULL
Drosophila	NULL
segmentation	NULL
gene	NULL
,	NULL
runt	NULL
.	NULL

Blood	NULL
80:1825	NULL
,	NULL
1992	NULL
65	NULL
.	NULL

Miyoshi	NULL
H	NULL
,	NULL
Kozu	NULL
T	NULL
,	NULL
Shimizu	NULL
K	NULL
,	NULL
Enomoto	NULL
K	NULL
,	NULL
Maseki	NULL
N	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Kamada	NULL
N	NULL
,	NULL
Ohki	NULL
M	NULL
:	NULL
The	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
results	NULL
in	NULL
production	NULL
of	NULL
an	NULL
AMLI-MTGS	NULL
fusion	NULL
transcript	NULL
.	NULL

EMBO	NULL
J	NULL
12	NULL
;	NULL
:2715	NULL
,	NULL
1993	NULL
66	NULL
.	NULL

Nucifora	NULL
G	NULL
,	NULL
Begy	NULL
CR	NULL
,	NULL
Erickson	NULL
P	NULL
,	NULL
Drabkin	NULL
H	NULL
,	NULL
Rowley	NULL
JD	NULL
:	NULL
The	NULL
3	NULL
;	NULL
21	NULL
translocation	NULL
in	NULL
myelodysplasia	NULL
results	NULL
in	NULL
a	NULL
fusion	NULL
transcript	NULL
between	NULL
the	NULL
AMLI	NULL
gene	NULL
and	NULL
the	NULL
gene	NULL
for	NULL
EAP	NULL
,	NULL
a	NULL
highly	NULL
conserved	NULL
protein	NULL
associated	NULL
with	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
small	NULL
RNA	NULL
EBER	NULL
1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:7784	NULL
,	NULL
1993	NULL
67	NULL
.	NULL

Nucifora	NULL
G	NULL
,	NULL
Begy	NULL
CR	NULL
,	NULL
Kobayashi	NULL
H	NULL
,	NULL
Roulston	NULL
D	NULL
,	NULL
Claxton	NULL
D	NULL
,	NULL
Pedersen-Bjergaard	NULL
J	NULL
,	NULL
Parganas	NULL
E	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Rowley	NULL
JD	NULL
:	NULL
Consistent	NULL
intergenic	NULL
splicing	NULL
and	NULL
production	NULL
of	NULL
multiple	NULL
transcripts	NULL
between	NULL
AML1	NULL
at	NULL
21q22	NULL
and	NULL
unrelated	NULL
genes	NULL
at	NULL
3q26	NULL
in	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
;	NULL
q22	NULL
)	NULL
translocations	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:4004	NULL
,	NULL
1994	NULL
68	NULL
.	NULL

Claxton	NULL
DF	NULL
,	NULL
Liu	NULL
P	NULL
,	NULL
Hsu	NULL
HB	NULL
,	NULL
Marlton	NULL
P	NULL
,	NULL
Hester	NULL
J	NULL
,	NULL
Collins	NULL
F	NULL
,	NULL
Deisseroth	NULL
AB	NULL
,	NULL
Rowley	NULL
JD	NULL
,	NULL
Siciliano	NULL
MJ	NULL
:	NULL
Detection	NULL
of	NULL
fusion	NULL
transcripts	NULL
generated	NULL
by	NULL
the	NULL
inversion	NULL
16	NULL
chromosome	NULL
in	NULL
acute	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

Blood	NULL
83:1750	NULL
,	NULL
1994	NULL
69	NULL
.	NULL

Rabbitts	NULL
TH	NULL
:	NULL
Translocations	NULL
,	NULL
master	NULL
genes	NULL
,	NULL
and	NULL
differences	NULL
between	NULL
the	NULL
origins	NULL
of	NULL
acute	NULL
and	NULL
chronic	NULL
leukemias	NULL
.	NULL

Cell	NULL
67:641	NULL
,	NULL
1991	NULL
70	NULL
.	NULL

Sakakura	NULL
C	NULL
,	NULL
Yamaguchi-Iwai	NULL
Y	NULL
,	NULL
Satake	NULL
M	NULL
,	NULL
Bae	NULL
S-C	NULL
,	NULL
Takahashi	NULL
A	NULL
,	NULL
Ogawa	NULL
E	NULL
,	NULL
Hagiwara	NULL
A	NULL
,	NULL
Takahashi	NULL
T	NULL
,	NULL
Murakami	NULL
A	NULL
,	NULL
Makino	NULL
K	NULL
,	NULL
Nakagawa	NULL
T	NULL
,	NULL
Kamada	NULL
N	NULL
,	NULL
Ito	NULL
Y	NULL
:	NULL
Growth	NULL
inhibition	NULL
and	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
by	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
PEBP2	NULL
and	NULL
the	NULL
AMLI/MTG8	NULL
(	NULL
ETO	NULL
)	NULL
-spe-cific	NULL
antisense	NULL
oligonucleotide	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:11723	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blO	NULL
Od®	NULL
1995	NULL
86	NULL
:	NULL
607-616	NULL
Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
activity	NULL
by	NULL
AML1-related	NULL
transcription	NULL
factor	NULL
,	NULL
PEBP2	NULL
A	NULL
Takahashi	NULL
,	NULL
M	NULL
Satake	NULL
,	NULL
Y	NULL
Yamaguchi-lwai	NULL
,	NULL
SC	NULL
Bae	NULL
,	NULL
J	NULL
Lu	NULL
,	NULL
M	NULL
Maruyama	NULL
,	NULL
YW	NULL
Zhang	NULL
,	NULL
H	NULL
Oka	NULL
,	NULL
N	NULL
Arai	NULL
and	NULL
K	NULL
Arai	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
“	NULL
f.9	NULL
'	NULL
.	NULL
'	NULL

e	NULL
>	NULL
\	NULL
/	NULL
{	NULL
®	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/86/2/607.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

